Cocaine#Basic

Cocaine
Clinical data
Pronunciationkə(ʊ)ˈkeɪn
Trade namesNeurocaine,[1] Goprelto,[2] Numbrino,[3] others
Other namesBenzoylmethylecogine
AHFS/Drugs.comMicromedex Detailed Consumer Information
License data
Dependence
liability
Physical: Low Psychological: High[4]
Addiction
liability
High[5]
Routes of
administration
Topical, by mouth, insufflation, intravenous, inhalation
Drug class
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability
MetabolismLiver, CYP3A4
MetabolitesNorcocaine, benzoylecgonine, cocaethylene (when consumed with alcohol)
Onset of actionSeconds to minutes[13]
Duration of action20 to 90 minutes[13]
ExcretionKidney
Identifiers
  • Methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
CompTox Dashboard (EPA)
ECHA InfoCard100.000.030 Edit this at Wikidata
Chemical and physical data
FormulaC17H21NO4
Molar mass303.358 g·mol−1
3D model (JSmol)
Melting point98 °C (208 °F)
Boiling point187 °C (369 °F)
Solubility in water1.8g/L (22 °C)
  • CN1[C@H]2CC[C@@H]1[C@@H](C(OC)=O)[C@@H](OC(C3=CC=CC=C3)=O)C2
  • InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1 checkY
  • Key:ZPUCINDJVBIVPJ-LJISPDSOSA-N checkY
Data page
Cocaine (data page)
 ☒NcheckY (what is this?)  (verify)

Cocaine is a tropane alkaloid and central nervous system stimulant derived primarily from the leaves of two coca species native to South America: Erythroxylum coca and E. novogranatense.[14][15][16][17][18] Indigenous South Americans have used coca leaves for over a thousand years. Today, cocaine is rarely used medically, primarily as a topical medication, having been replaced due to its high abuse potential, adverse effects, and high cost.[19][20]

Street cocaine is typically snorted, injected, or smoked as crack cocaine, with effects beginning within seconds to minutes and lasting up to 90 minutes depending on the route.[13][21] Pharmacologically, it is a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) that activates the mesolimbic pathway.[6][7][22][17] Reinforcing effects include euphoria, improved alertness and concentration, increased libido, a general sense of well-being, and reduced fatigue and appetite.[23]

Cocaine has numerous adverse effects. Short-term risks include vasoconstriction, tachycardia, hypertension, hyperthermia, anxiety, irritability, psychosis, and seizures.[13] Overdose may result in stroke, heart attack, or sudden cardiac death.[17][24] Use during pregnancy can lead to prenatal cocaine exposure, affecting fetal development.[25][26][27][28] Chronic use may cause cocaine dependence, withdrawal symptoms, and nasal damage, including cocaine-induced midline destructive lesions when insufflated.[29][30][31][32][33]

Large-scale biosynthesis of cocaine is unexplored;[34] As a result, the coca leaves are processed into cocaine paste and subsequently into powdered cocaine hydrochloride salt. According to a 2006 report by the UNODC, 99% of all global illicit cocaine is sourced from coca plantations in the Andes of South America—primarily in Colombia, Peru, and Bolivia.[18] While most coca cultivation remains concentrated in South America, recent years have seen rapid expansion into northern Central America, specifically in Honduras, Guatemala, and Belize.[35][36][37][38]

Cocaine is prohibited globally except for restricted medical and scientific uses under treaties like the international drug control conventions. Nevertheless, legal penalties vary by country. Some jurisdictions decriminalize possession of small amounts, leading to inconsistency in the legal status of cocaine worldwide.[39][40][41][42]

Uses

[edit]

Coca leaves have been used by Andean civilizations since ancient times.[43] In ancient Wari culture,[44] Inca culture, and through modern successor indigenous cultures of the Andes mountains, coca leaves are chewed, taken orally in the form of a tea, or alternatively, prepared in a sachet wrapped around alkaline burnt ashes, and held in the mouth against the inner cheek; it has traditionally been used as an anorectic and to combat the effects of cold and altitude sickness,[45][46] although its actual effectiveness has never been systematically studied.[47]

Globally, in 2019, cocaine was used by an estimated 20 million people (0.4% of adults aged 15 to 64 years). The highest prevalence of cocaine use was in Australia and New Zealand (2.1%), followed by North America (2.1%), Western and Central Europe (1.4%), and South and Central America (1.0%).[48] Since 1961, the Single Convention on Narcotic Drugs has required countries to make recreational use of cocaine a crime.[49] In the United States, cocaine is regulated as a Schedule II drug under the Controlled Substances Act, meaning that it has a high potential for abuse but has an accepted medical use.[50] While rarely used medically today, its accepted uses include serving as a topical local anesthetic for the upper respiratory tract and as an antihemorrhagic agent to stop bleeding in the mouth, throat, and nasal cavities.[51]

Traditional medicine

[edit]

Coca leaves

[edit]
Llipta is used to improve extraction when chewing coca (Museo de la Coca, Cusco, Peru).

It is legal for people to use coca leaves in the Andean Community, such as Peru and Bolivia, where they are chewed, consumed in the form of tea, or are sometimes incorporated into food products.[52] Coca leaves are typically mixed with an alkaline substance (such as lime) and chewed into a wad that is retained in the buccal pouch (mouth between gum and cheek, much the same as chewing tobacco is chewed) and sucked of its juices. The juices are absorbed slowly by the mucous membrane of the inner cheek and by the gastrointestinal tract when swallowed.

Coca tea
[edit]
Two cups of coca tea

Coca herbal infusion (also referred to as coca tea) is used in coca-leaf producing countries much as any herbal medicinal infusion would elsewhere in the world. The free and legal commercialization of dried coca leaves under the form of filtration bags to be used as "coca tea" has been actively promoted by the governments of Peru and Bolivia for many years as a drink having medicinal powers. In Peru, the National Coca Company, a state-run corporation, sells cocaine-infused teas and other medicinal products and also exports leaves to the U.S. for medicinal use.[53] The effects of drinking coca tea are mild stimulation and mood lift.[54]

In 1986 an article in the Journal of the American Medical Association revealed that U.S. health food stores were selling dried coca leaves to be prepared as an infusion as "Health Inca Tea". While the packaging claimed it had been "decocainized", no such process had actually taken place. The article stated that drinking two cups of the tea per day gave a mild stimulation, increased heart rate, and mood elevation, and the tea was essentially harmless.[55]

Ypadu
[edit]
Mambe or ypadu is made from toasted and ground coca leaves with ashes

Ypadú or ypadu (also known as mambé) is an unrefined, unconcentrated powder made from toasted coca leaves and the ash of various other plants. It is traditionally prepared and consumed by indigenous tribes in the Northwest Amazon.[56] Like coca teas consumed in Peru to adapt to sickness induced by high elevation, it has a long ethnobotanical history and cultural associations.

Medical

[edit]

Karl Koller’s groundbreaking discovery of cocaine as a local anesthetic is regarded as the second most significant advance in the history of anesthesia. Although cocaine was once widely preferred for topical anesthesia, the search for replacement agents intensified due to rising costs, strict regulations, and its habit-forming potential. Today, the US Drug Enforcement Administration (DEA) classifies cocaine as a Schedule II drug, recognizing its high potential for abuse but still permitting its limited use for medical purposes.

However, current pharmacoepidemiological trends suggest that cocaine may soon reach the point where, in practical terms, it is no longer used medically in health care as a Schedule II substance. This report may prompt some states (such as North Dakota) and institutions to reconsider whether further efforts to identify alternative agents are needed. As physician boards—but not pharmacy boards—continue to assess knowledge of licit cocaine, attention may shift toward drugs with more contemporary medical use.[20]

Cocaine is rarely prescribed in modern medicine due to its high potential for abuse and significant risk of adverse effects; its use is now almost exclusively limited to health facilities for specific diagnostic procedures or surgeries.

Topical

[edit]

Cocaine is used in medical practice as a topical medication.[20] Because it is not absorbed into the bloodstream in significant amounts when used this way, topical application does not produce the psychoactive effects associated with recreational cocaine use.

Topical anesthetic
[edit]
Cocaine hydrochloride

Cocaine is sometimes used in otorhinolaryngology as a topical anesthetic and vasoconstrictor to help control pain and bleeding during surgery of the nose, mouth, throat, or lacrimal duct. It is also used for topical airway anaesthesia for procedures such as awake fibreoptic bronchoscopy or intubation. Although some absorption and systemic effects may occur, the use of cocaine as a topical anesthetic and vasoconstrictor is generally safe, rarely causing cardiovascular toxicity, glaucoma, and pupil dilation.[57][19] Occasionally, cocaine is mixed with adrenaline and sodium bicarbonate and used topically for surgery, a formulation called Moffett's solution.[58] It is occasionally used in surgeries involving the pharynx or nasopharynx to reduce pain, bleeding, and vocal cord spasm.[59]

Nasal solution cocaine hydrochloride (Goprelto), an ester used for intranasal application, was approved for medical use in the United States in December 2017, and is indicated for the introduction of topical anesthesia of the mucous membranes for diagnostic procedures and surgeries on or through the nasal cavities of adults.[60][2] Cocaine hydrochloride (Numbrino) was approved for medical use in the United States in January 2020.[61][3] Headache and epistaxis are the most frequently reported adverse reactions with Goprelto,[2] while hypertension and tachycardia-including sinus tachycardia-are most common with Numbrino.[3]

Ophthalmological use
[edit]

Cocaine is an ophthalmological agent classified under ATC code S01HA Local anesthetics.

Cocaine eye drops are frequently used by neurologists when examining people suspected of having Horner syndrome. In Horner syndrome, sympathetic innervation to the eye is blocked. In a healthy eye, cocaine stimulates the sympathetic nervous system (SNS) by inhibiting norepinephrine reuptake, causing the pupil to dilate. In patients with Horner syndrome, sympathetic innervation to the eye is disrupted, so the affected pupil does not dilate in response to cocaine and remains constricted, or dilates to a lesser extent than the unaffected eye, which also receives the eye drop test. If both eyes dilate equally, the patient does not have Horner syndrome.[62]

Recreational

[edit]
Peruvian flake cocaine on a metal milligram scale tray

Recreational cocaine is typically not taken by mouth due to its poor bioavailability, instead it is usually snorted, injected. Cocaine hydrochloride can also be chemically converted into its free base form, crack cocaine, which can be vaporized.

Cocaine is a central nervous system stimulant.[63] Its effects can last from 15 minutes to an hour. The duration of cocaine's effects depends on the amount taken and the route of administration.[64] Cocaine can be in the form of fine white powder and has a bitter taste. Crack cocaine is a smokeable form of cocaine made into small "rocks" by processing cocaine with sodium bicarbonate (baking soda) and water.[13][65]

Cocaine use leads to increases in alertness, feelings of well-being and euphoria, increased energy and motor activity, and increased feelings of competence and sexuality.[66]

Analysis of the correlation between the use of 18 various psychoactive substances shows that cocaine use correlates with other "party drugs" (such as ecstasy or amphetamines), as well as with heroin and benzodiazepines use, and can be considered as a bridge between the use of different groups of drugs.[67]

In 2023, David Liddell of the Scottish Drugs Forum reported a rise in cocaine use, particularly among people with long-term drug problems, and noted that stigma often delays users from seeking help until their issues become severe.[68]

Insufflation

[edit]
Lines of cocaine prepared for snorting. Contaminated currency such as banknotes might serve as a fomite of diseases like hepatitis C[69]

Nasal insufflation (known colloquially as "snorting", "sniffing", or "blowing") is a common method of ingestion of recreational powdered cocaine.[70] The drug coats and is absorbed through the mucous membranes lining the nasal passages. Cocaine's desired euphoric effects are delayed when snorted through the nose by about five minutes. This occurs because cocaine's absorption is slowed by its constricting effect on the blood vessels of the nose.[13] Insufflation of cocaine also leads to the longest duration of its effects (60–90 minutes).[13] When insufflating cocaine, absorption through the nasal membranes is approximately 30–60%[71]

In a study of cocaine users, the average time taken to reach peak subjective effects was 14.6 minutes.[72] Any damage to the inside of the nose is due to cocaine constricting blood vessels — and therefore restricting blood and oxygen/nutrient flow — to that area, which, after chronic use, may cause "cocaine nose."

Most banknotes have traces of cocaine on them; this has been confirmed by studies done in several countries.[73] In 1994, the U.S. 9th Circuit Court of Appeals cited findings that in Los Angeles, three out of four banknotes were tainted by cocaine or another illicit drug.[74][75]

Snuff spoons, hollowed-out pens, cut straws, pointed ends of keys,[76] long fingernails or artificial nails, and (clean) tampon applicators are also used to insufflate cocaine. The cocaine typically is poured onto a flat, hard surface (such as a mobile phone screen, plate, mirror, CD case or book) and divided into "bumps", "lines" or "rails", and then insufflated.[77] A 2001 study reported that the sharing of straws used to "snort" cocaine can spread blood diseases such as hepatitis C.[78]

Cocaine spoon
[edit]
Chinese snuff bottle stopper with a spoon

Historically, snuff spoons were used for cocaine in the 20th century, hence the names "cocaine spoon" and "coke spoon". Some local statutes in the US treat spoons that are too small and thus "unsuited for the typical, lawful uses of a spoon" as drug paraphernalia.[79][80][81]

In the US, McDonald's provides straight swizzle sticks to stir the coffee, while in the rest of the world a small plastic stirring spoon is used. According to Anthony J. Graybosch, this is due to the 1960s rumor that the spoons can be used to snort cocaine.[82]

Injection

[edit]

Subjective effects not commonly shared with other methods of administration include a ringing in the ears moments after injection (usually when over 120 milligrams) lasting 2 to 5 minutes including tinnitus and audio distortion. This is colloquially referred to as a "bell ringer". In a study of cocaine users, the average time taken to reach peak subjective effects was 3.1 minutes.[72] The euphoria passes quickly. Aside from the toxic effects of cocaine, there is also the danger of circulatory emboli from the insoluble substances that may be used to cut the drug. As with all injected illicit substances, there is a risk of the user contracting blood-borne infections if sterile injecting equipment is not available or used.

Inhalation

[edit]
Crack cocaine
[edit]
Man smoking crack cocaine in Bogotá, Colombia

Powder cocaine (cocaine hydrochloride) must be heated to a high temperature (about 197 °C), and considerable decomposition/burning occurs at these high temperatures. This effectively destroys some of the cocaine and yields a sharp, acrid, and foul-tasting smoke. Cocaine base/crack can be smoked because it vaporizes with little or no decomposition at 98 °C (208 °F),[83] which is below the boiling point of water.

Contraindications

[edit]

Cocaine should not be used in individuals with a known allergy or hypersensitivity to the drug or any components of its topical formulation. It is also contraindicated in elderly patients and those with a history of hypertension or cardiovascular disease.[84]

Pregnancy

[edit]

Prenatal cocaine exposure (PCE) may occur when a pregnant woman uses cocaine.[25][26][27][28]

Under the former FDA pregnancy category system, cocaine was classified as a Category C drug. Its potential to cause harm to the fetus is not fully known, so it should only be administered to pregnant women if clearly necessary.[84]

Cocaine can act as a teratogen, having various effects on the developing fetus.[85] Some common teratogenic defects caused by cocaine include hydronephrosis, cleft palate, polydactyly, and down syndrome.[85] Cocaine as a drug has a low molecular weight and high water and lipid solubility which enables it to cross the placenta and fetal blood-brain barrier.[86] Because cocaine is able to pass through the placenta and enter the fetus, the fetus' circulation can be negatively affected. With restriction of fetal circulation, the development of organs in the fetus can be impacted, even resulting in intestines developing outside of the fetus' body.[85] Cocaine use during pregnancy can also result in obstetric labor complications such as premature labor,[87] placental abruption,[88] preterm birth or delivery, uterine rupture, miscarriage, and stillbirth.[85]

Breastfeeding

[edit]

Mothers utilizing recreational drugs, such as cocaine, methamphetamines, PCP, and heroin, should not breastfeed.[89][90]: 13 

The March of Dimes said "it is likely that cocaine will reach the baby through breast milk," and advises the following regarding cocaine use during pregnancy:

Cocaine use during pregnancy can affect a pregnant woman and her unborn baby in many ways. During the early months of pregnancy, it may increase the risk of miscarriage. Later in pregnancy, it can trigger preterm labor (labor that occurs before 37 weeks of pregnancy) or cause the baby to grow poorly. As a result, cocaine-exposed babies are more likely than unexposed babies to be born with low birth weight (less than 5.5 lb or 2.5 kg). Low-birthweight babies are 20 times more likely to die in their first month of life than normal-weight babies, and face an increased risk of lifelong disabilities such as mental retardation and cerebral palsy. Cocaine-exposed babies also tend to have smaller heads, which generally reflect smaller brains. Some studies suggest that cocaine-exposed babies are at increased risk of birth defects, including urinary tract defects and, possibly, heart defects. Cocaine also may cause an unborn baby to have a stroke, irreversible brain injury, or a myocardial infarction.[91]

Adverse effects

[edit]

Cardiac complications

[edit]

Cocaine use can cause serious heart problems like sudden death, heart inflammation, arrhythmias, and heart attacks. It triggers coronary artery spasms, increases blood clot risk, and accelerates atherosclerosis, especially with long-term use. The severity of heart disease often relates to how long and how often cocaine is used.[94] It can also become a serious risk at high doses due to cocaine's blocking effect on cardiac sodium channels.[95]

Levamisole syndromes

[edit]

Globally, levamisole is now one of the most common adulterants found in illicit cocaine, with studies showing that between 2009 and 2016, 50–70% of all cocaine specimens worldwide contained levamisole, reflecting similar high rates of contamination across North America and Europe.[96] Before trafficking to the United States, the cocaine is frequently adulterated with levamisole.[97] By October 2017, this figure had risen further, with the DEA reporting that 87% of seized and analyzed cocaine bricks in the United States contained levamisole, making it the most common adulterant in cocaine at that time.[98]

In the body, levamisole is converted into aminorex, a substance with amphetamine-like stimulant effects and a long duration of action.[99] Levamisole-adulterated cocaine is associated with cocaine- and levamisole-induced vasculitis (CLIV) and cocaine/levamisole-associated autoimmune syndrome (CLAAS).[100][101] Reagent testing kits can be used to detect the presence of cocaine and levamisole.[102]

Levamisole induced necrosis syndrome

[edit]

Levamisole induced necrosis syndrome (LINES) is a complication characterized by necrosis resulting from exposure to levamisole, a medication with immunomodulatory properties. While LINES can occur with levamisole use alone, most reported cases are associated with the use of cocaine adulterated with levamisole as a cutting agent. This syndrome is marked by skin necrosis, often affecting areas such as the ears, face, and extremities, and is thought to result from levamisole’s effects on blood vessels and the immune system.[103]

Cocaine/levamisole-associated syndromes

[edit]

The skin necrosis associated with levamisole toxicity ranges from leukocytoclastic vasculitis to occlusive vasculopathy. Several cases of severe agranulocytosis associated with cocaine use have been reported since 2006. With the recently recognized dermal disease, the face and ears are commonly affected, especially the bilateral helices and cheeks. However, there have also been case reports of involvement of the abdomen, chest, lower buttocks and legs.[104][105]

During the mid-2010s, levamisole was found in most cocaine products available in both the United States and Europe.[106] Levamisole is known to cause an acute condition involving a severe and dangerous lowered white blood cell count, known as agranulocytosis, in cocaine users, and may also accentuate cocaine's effects.[107][108][109]

Clinical studies have shown that taking levamisole at doses of 50–200 mg per day can lead to agranulocytosis in approximately 0.08–5% of patients.[110]

Cocaine- and levamisole-induced vasculitis
[edit]

Cocaine- and levamisole-induced vasculitis (CLIV) is often used as an umbrella term for the vasculitic and necrotic complications seen with levamisole-adulterated cocaine, including both LINES and CLAAS.[100]

Cocaine and levamisole-adulterated cocaine (LAC) can cause cocaine-induced vasculitis (CIV) that mimics primary anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), presenting as cocaine-induced midline destructive lesions, LAC vasculopathy, or CIV. These conditions involve immune activation through NETosis and ANCA formation, leading to tissue damage. Diagnosis is challenging due to symptom overlap and undisclosed drug use, making clinical suspicion and drug history essential for proper management.[111]

Cocaine/levamisole-associated autoimmune syndrome
[edit]

The broader cocaine/levamisole-associated autoimmune syndrome (CLAAS) includes LINES as a subset and is also common, but LINES is more specifically and frequently cited in the context of street cocaine adulteration.[101]

Levamisole has become a common additive to illicit cocaine. It is thought to intensify the "high" by releasing dopamine in the brain, acts as a bulking agent, and is a difficult adulterant to recognize. Potential risks of levamisole-laced cocaine include autoimmune disease, neutropenia, arthralgias, retiform purpura, skin necrosis, and fever.[112]

Mortality

[edit]

Persons with regular or problematic use of cocaine have a significantly higher mortality rate, and are specifically at higher risk of traumatic deaths and deaths attributable to infectious disease.[113] In 2025, the Liberty House Clinic in the United Kingdom noted that chronic cocaine usage in fact had a higher risk of death than alcoholism.[114]

Neurotoxicity

[edit]

Cocaine is considered neurotoxic due to its damaging effects on the brain and nervous system.[115][116][117] Research has shown that both acute and chronic cocaine use can lead to significant reductions in cerebral blood flow, disrupt neurovascular interactions, and impair brain function. These changes are associated with nerve injury, cognitive deficits, and an increased risk of cerebrovascular accidents such as strokes. Brain imaging studies consistently report that individuals who misuse cocaine exhibit structural and functional abnormalities compared to non-users, supporting the classification of cocaine as a neurotoxic substance.[115]

Psychosis

[edit]

Cocaine has a similar potential to induce temporary psychosis[118] with more than half of cocaine abusers reporting at least some psychotic symptoms at some point.[119] Typical symptoms include paranoid delusions that they are being followed and that their drug use is being watched, accompanied by hallucinations that support the delusional beliefs.[119] Delusional parasitosis with formication ("cocaine bugs") is also a fairly common symptom.[120]

Cocaine-induced psychosis shows sensitization toward the psychotic effects of the drug. This means that psychosis becomes more severe with repeated intermittent use.[119][121]

Short-term effects

[edit]

Insufflating (snorting) cocaine commonly causes increased mucus production due to irritation and inflammation of the nasal passages. This irritation leads to symptoms such as a runny nose, nasal congestion, and excessive or thickened mucus.

Acute exposure to cocaine has many effects on humans, including euphoria, increases in heart rate and blood pressure, and increases in cortisol secretion from the adrenal gland.[122] In humans with acute exposure followed by continuous exposure to cocaine at a constant blood concentration, the acute tolerance to the chronotropic cardiac effects of cocaine begins after about 10 minutes, while acute tolerance to the euphoric effects of cocaine begins after about one hour.[123][124][125][126] With excessive or prolonged use, the drug can cause itching, fast heart rate, and paranoid delusions or sensations of insects crawling on the skin.[127] Intranasal cocaine and crack use are both associated with pharmacological violence. Aggressive behavior may be displayed by both addicts and casual users. Cocaine can induce psychosis characterized by paranoia, impaired reality testing, hallucinations, irritability, and physical aggression. Cocaine intoxication can cause hyperawareness, hypervigilance, psychomotor agitation, and delirium. Consumption of large doses of cocaine can cause violent outbursts, especially by those with preexisting psychosis.[128] Acute exposure may induce arrhythmia, including atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, and ventricular fibrillation. Acute exposure may also lead to angina, heart attack, and congestive heart failure.[129] Cocaine overdose may cause seizures, abnormally high body temperature and a marked elevation of blood pressure, which can be life-threatening,[127] abnormal heart rhythms,[95] and death.[95] Anxiety, paranoia, and restlessness can also occur, especially during the comedown. With excessive dosage, tremors, convulsions, and increased body temperature are observed.[63]

Long-term effects

[edit]
Side effects of chronic cocaine use

Cocaine is highly addictive and has poor bioavailability when taken orally. Individuals often engage in repeated use by either insufflating it intranasally or converting it to crack cocaine for vaporization. Cocaine's effects last longest when insufflated (60–90 minutes),[13] but the drug itself has a short biological half-life of about 0.7–1.5 hours.[130] Repeated use raises the risk of developing "cocaine nose," referring to severe nasal tissue damage from intranasal use, as well as "crack lung," a condition involving lung tissue damage caused by inhaling crack cocaine.

Cocaine use leads to an increased risk of hemorrhagic and ischemic strokes.[65] Cocaine use also increases the risk of having a heart attack.[131]

Cocaine use also promotes the formation of blood clots.[13] This increase in blood clot formation is attributed to cocaine-associated increases in the activity of plasminogen activator inhibitor, and an increase in the number, activation, and aggregation of platelets.[13]

Cocaine constricts blood vessels, dilates pupils, and increases body temperature, heart rate, and blood pressure. It can also cause headaches and gastrointestinal complications such as abdominal pain and nausea. Chronic users may lose their appetite and experience severe malnutrition, leading to being underweight.

Although it has been commonly asserted, the available evidence does not show that chronic use of cocaine is associated with broad cognitive impairment.[132] Research is inconclusive on age-related loss of striatal dopamine transporter (DAT) sites, suggesting cocaine has neuroprotective or neurodegenerative properties for dopamine neurons.[133][134][135] Exposure to cocaine may lead to the breakdown of the blood–brain barrier.[136][137]

The misuse of cocaine has a high correlation with suicide.[138][139] In those who use cocaine, the risk is greatest during the withdrawal phase.[140]

Chronic cocaine use, but not cocaine itself, can contribute to tooth wear and the development of tooth decay through indirect mechanisms.[clarification needed] Cocaine use is frequently associated with involuntary tooth grinding, known as bruxism, which can cause dental attrition and gingivitis.[141][142] Additionally, stimulants like cocaine, methamphetamine, and even caffeine cause dehydration and dry mouth. Since saliva is an important mechanism in maintaining one's oral pH level, people who use cocaine over a long period of time who do not hydrate sufficiently may experience demineralization of their teeth due to the pH of the tooth surface dropping too low (below 5.5). Poor oral hygiene, which is common among individuals with substance use disorders, may contribute significantly to tooth decay in cocaine users.[citation needed]

Addiction

[edit]

Cocaine can induce tolerance after a single dose, and repeated use frequently leads to the development of addiction and prolonged craving.[123][143][144] Withdrawal symptoms include disrupted sleep, irritability, depression, and reduced ability to experience pleasure (anhedonia).[145][17] Chronic nasal use may cause destructive damage to the nasal septum, including cocaine-induced midline destructive lesions (CIMDL). Illicit cocaine is frequently adulterated with substances such as fentanyl, levamisole, or local anesthetics, increasing its toxicity.[43][146] Concurrent use with alcohol produces cocaethylene, a metabolite that significantly increases the risk of sudden death. According to the Global Burden of Disease Study, cocaine use is responsible for approximately 7,300 deaths annually.[147]

Cocaine abuse can trigger addiction-related structural neuroplasticity in the human brain, although the permanence of such changes remains uncertain.[148] Family history is a known risk factor, as relatives of cocaine users have an increased likelihood of developing cocaine addiction.[149] A key mechanism involves the overexpression of ΔFosB in the nucleus accumbens, altering transcriptional regulation and reinforcing drug-seeking behavior.[150] Each dose of cocaine raises ΔFosB levels without a known saturation point. This elevation leads to increased brain-derived neurotrophic factor (BDNF) levels, which in turn enhance dendritic branching and spine density in neurons of the nucleus accumbens and prefrontal cortex, potentially persisting for weeks after drug cessation.[citation needed]

In transgenic mice engineered to express ΔFosB in the nucleus accumbens and dorsal striatum, heightened behavioral sensitization to cocaine has been observed.[151] These mice self-administer cocaine at lower doses and display a greater propensity for relapse after withdrawal[152][153] ΔFosB also enhances sensitivity to reward by upregulating the AMPA receptor subunit GluR2[151] and downregulating the expression of dynorphin.[153]

Cocaine use has also been shown to increase DNA damage in the brains of rodents.[154][155] During subsequent DNA repair, enduring alterations in chromatin structure may arise, such as DNA methylation and methylation or acetylation of histones at the repair loci.[156] These modifications may result in lasting epigenetic "scars", which are believed to contribute to the persistent epigenetic changes observed in cocaine addiction.

Dependence and withdrawal

[edit]

Cocaine dependence develops after even brief periods of regular cocaine use.[29]

Cocaine withdrawal symptoms group into two types: depressive (e.g., depression, craving, insomnia) and somatic (e.g., increased appetite, fatigue). Depressive symptoms are linked to worse outcomes like longer depression, treatment, and risky behaviors.[30]

Treatment
[edit]

Because there are no medications with an approved indication for cocaine use disorder, psychosocial treatments are the current standard. Effective approaches include group and individual counseling, cognitive behavioral therapy (CBT), and motivational interviewing (MI). Contingency management (CM)—which rewards patients with vouchers for meeting treatment goals—has proven especially effective, particularly for helping patients achieve initial abstinence from cocaine.[157]

Cocaine Anonymous sobriety coins

Cocaine Anonymous (CA) is a twelve-step program formed in 18 November 1982 for people who seek recovery from drug addiction. It is patterned very closely after Alcoholics Anonymous (AA), although the two groups are unaffiliated. While many CA members have been addicted to cocaine, crack, speed or similar substances, CA accepts all who desire freedom from "cocaine and all other mind-altering substances" as members.[158]

Numerous medications have been investigated for use in cocaine dependence, but as of 2015, none of them were considered to be effective.[159] Drugs which help to re-stabilize the glutamate system such as N-acetylcysteine have been proposed for the treatment of addiction to cocaine, nicotine, and alcohol.[160] However, none have sufficient evidence or regulatory approval for routine clinical use, so psychosocial interventions remain the mainstay of treatment.[157]

Cocaine nose

[edit]
Nasal septum perforation caused by cocaine insufflation (pictured) can progress to cocaine-induced midline destructive lesions

"Cocaine nose" or "coke nose" are informal terms that refer to nose disorders resulting from repeated or chronic cocaine use.[31][161][162][163]

About 30% of people who had snorted cocaine at least 25 times but less than daily, and 47% of daily users, reported experiencing nasal irritation, crusting or scabbing, and frequent nosebleeds. Cocaine use should be considered as a potential cause of persistent or unexplained rhinitis, including in adolescent patients.[164]

Because the nose is a prominent facial feature, such visible damage often leads to embarrassment, stigma, and negative reactions from others. As a result, individuals with cocaine-induced nasal damage frequently withdraw from social activities and relationships, leading to social isolation. In many cases, this isolation is not just likely but almost inevitable, as affected individuals may feel unable to face the outside world due to the noticeable and sometimes severe changes to their appearance.[165][166]

Nose disorders associated with cocaine nose include:

Cocaine-induced midline destructive lesions
[edit]

Cocaine-induced midline destructive lesions (CIMDL), colloquially known as "coke nose",[32] is the progressive destruction of nasal architecture with the erosion of the palate, nasal conchae, and ethmoid sinuses associated with prolonged insufflation, colloquially 'snorting', of cocaine.[33]

Chronic intranasal usage can degrade the cartilage separating the nostrils (the septum nasi), leading eventually to its complete disappearance.[168]

Causes
[edit]

The cause of "cocaine nose" can be traced to the chemical process that occurs when cocaine hydrochloride is insufflated (snorted). As cocaine is absorbed through the nasal mucosa, the remaining hydrochloride component forms a dilute hydrochloric acid.[168] The short half-life of cocaine,[130] combined with binge use, may expose the nasal tissues to this acidic environment more frequently, increasing the risk of irritation and damage.

Treatment
[edit]

For people with cocaine abuse, mild symptoms may resolve completely with total abstinence from cocaine, making early involvement of addiction services essential.[169]

Repair may involve rhinoplasty, which includes creating a new internal lining with nasolabial flaps and restoring support with costal cartilage grafts.[170]

In 2024, Belgian doctors report a rise in patients needing nose reconstruction due to cocaine use, which damages nasal tissue and cartilage; however, few undergo surgery because it requires at least six months of abstinence from cocaine for proper healing.[171]

Some individuals seek plastic surgery to repair or reconstruct nasal damage caused by cocaine use, although surgical outcomes can be complicated by ongoing tissue loss and poor healing. When nasal damage is too severe for reconstruction, a nose prosthesis may be used to restore appearance and quality of life.[165][166]

Overdose

[edit]
Death rates from cocaine overdoses
US yearly overdose deaths involving cocaine.[172]

According to the European Union Drugs Agency, the estimated minimum lethal dose is 1.2 grams. However, sensitive individuals have died from as little as 30 milligrams applied to mucous membranes-an amount that is 40 times less than the minimum lethal dose. In contrast, addicts may tolerate doses as high as 5 grams per day.[14]

Cocaine can be snorted, swallowed, injected, or smoked. Most deaths due to cocaine are accidental but may also be the result of body packing or stuffing with rupture in the gastrointestinal tract. Alcohol impairment increases the likelihood of risk-taking behaviors and susceptibility to peer pressure, and also raises the risk of overdose due to the formation of cocaethylene (see the alcohol section).

Use of cocaine causes abnormally fast heart rhythms and a marked elevation of blood pressure (hypertension), which can be life-threatening. This can lead to death from acute myocardial infarction, acute respiratory failure (i.e., hypoxemia, with or without hypercapnia), stroke, cerebral hemorrhage, and sudden cardiac arrest.[173] Overdose can also cause acute hepatotoxicity—typically due to toxic metabolites—though most cases resolve quickly; however, fatal outcomes from multiple organ dysfunction syndrome are possible, and there is no specific antidote.[174] Cocaine overdose may result in hyperthermia as stimulation and increased muscular activity cause greater heat production. Heat loss is also inhibited by the cocaine-induced vasoconstriction.

In 2024, drug-related deaths in England and Wales reached their highest level in three decades, with a notable increase in fatalities involving cocaine and experts urging urgent government intervention to address the crisis. Martin Powell, from the charity Transform, which campaigns for the legal regulation of drugs, suggested that the recent rise in cocaine-related deaths in the UK may be due to the increased purity of cocaine, leading users to consume it more frequently and alongside other substances.[175]

Interactions

[edit]

Alcohol

[edit]

Alcohol interacts with cocaine in vivo to produce cocaethylene, another psychoactive substance which may be substantially more cardiotoxic than either cocaine or alcohol by themselves.[176][177]

MAOIs

[edit]

Monoamine oxidase inhibitors (MAOIs) should not be combined with other psychoactive substances (antidepressants, painkillers, stimulants, including prescribed, OTC and illegally acquired drugs, etc.) except under expert care.[citation needed]

Opioids

[edit]

The opioid epidemic now involves more overdose deaths with both opioids and cocaine, especially among non-Hispanic Blacks who are twice as likely to die from combined opioid-stimulant overdoses compared to non-Hispanic whites. Cocaine-related deaths in Blacks are similar to opioid deaths in whites. Risk factors include young age, education, urban living, mental disorders, and stress. It remains unclear if co-use is intentional. Recent studies expand focus beyond heroin to all opioids, reflecting changing overdose patterns.[178]

Pharmacology

[edit]

Pharmacokinetics

[edit]

The extent of absorption of cocaine into the circulatory system after nasal insufflation is similar to that after oral ingestion. The rate of absorption after nasal insufflation is limited by cocaine-induced vasoconstriction of capillaries in the nasal mucosa. Onset of absorption after oral ingestion is delayed because cocaine is a weak base with a pKa of 8.6, and is thus in an ionized form that is poorly absorbed from the gastric acid and easily absorbed from the alkaline duodenum.[12] The rate and extent of absorption from inhalation of cocaine is similar or greater than with intravenous injection, as inhalation provides access directly to the capillary bed. The delay in absorption after oral ingestion may account for the popular belief that cocaine bioavailability from the stomach is lower than after insufflation. Compared with ingestion, the faster absorption of insufflated cocaine results in quicker attainment of maximum drug effects. Snorting cocaine produces maximum physiological effects within 40 minutes and maximum psychotropic effects within 20 minutes. Physiological and psychotropic effects from nasally insufflated cocaine are sustained for approximately 40–60 minutes after the peak effects are attained.[179]

Cocaine crosses the blood–brain barrier via both a proton-coupled organic cation antiporter[180][181] and (to a lesser extent) via passive diffusion across cell membranes.[182] As of September 2022, the gene or genes encoding the human proton-organic cation antiporter had not been identified.[183]

Cocaine has a short elimination half life of 0.7–1.5 hours and is extensively metabolized by plasma esterases and also by liver cholinesterases, with only about 1% excreted unchanged in the urine.[13] The metabolism is dominated by hydrolytic ester cleavage, so the eliminated metabolites consist mostly of benzoylecgonine (BE), the major metabolite, and other metabolites in lesser amounts such as ecgonine methyl ester (EME) and ecgonine.[184][13] Further minor metabolites of cocaine include norcocaine, p-hydroxycocaine, m-hydroxycocaine, p-hydroxybenzoylecgonine (pOHBE), and m-hydroxybenzoylecgonine.[185]

Depending on liver and kidney functions, cocaine metabolites are detectable in urine between three and eight days. Generally speaking benzoylecgonine is eliminated from someone's urine between three and five days. In urine from heavy cocaine users, benzoylecgonine can be detected within four hours after intake and in concentrations greater than 150 ng/mL for up to eight days later.[186]

Detection in the body

[edit]

Body fluids

[edit]

Cocaine and its major metabolites may be quantified in blood, plasma, or urine to monitor for use, confirm a diagnosis of poisoning, or assist in the forensic investigation of a traffic or other criminal violation or sudden death. Most commercial cocaine immunoassay screening tests cross-react appreciably with the major cocaine metabolites, but chromatographic techniques can easily distinguish and separately measure each of these substances. When interpreting the results of a test, it is important to consider the cocaine usage history of the individual, since a chronic user can develop tolerance to doses that would incapacitate a cocaine-naive individual, and the chronic user often has high baseline values of the metabolites in his system. Cautious interpretation of testing results may allow a distinction between passive or active usage, and between smoking versus other routes of administration.[187]

Hair

[edit]

Hair analysis can detect cocaine metabolites in regular users until after the sections of hair grown during the period of cocaine use are cut or fall out.[188]

Pharmacodynamics

[edit]

Cocaine acts as a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI).[7][22] Cocaine increases levels of serotonin, norepinephrine, and dopamine in the synaptic cleft, leading to heightened post-synaptic activation, with dopamine contributing to euphoria and arousal, and the other monoamines enhancing additional effects.[7][189][190][191]

The pharmacodynamics of cocaine involve the complex relationships of neurotransmitters (inhibiting monoamine uptake in rats with ratios of about: serotonin:dopamine = 2:3, serotonin:norepinephrine = 2:5).[192][17] The most extensively studied effect of cocaine on the central nervous system is the blockade of the dopamine transporter protein. Dopamine neurotransmitter released during neural signaling is normally recycled via the transporter; i.e., the transporter binds the transmitter and pumps it out of the synaptic cleft back into the presynaptic neuron, where it is taken up into storage vesicles. Cocaine binds tightly at the dopamine transporter forming a complex that blocks the transporter's function. The dopamine transporter can no longer perform its reuptake function, and thus dopamine accumulates in the synaptic cleft. The increased concentration of dopamine in the synapse activates post-synaptic dopamine receptors, which makes the drug rewarding and promotes the compulsive use of cocaine.[193]

Cocaine affects certain serotonin (5-HT) receptors; in particular, it has been shown to antagonize the 5-HT3 receptor, which is a ligand-gated ion channel. An overabundance of 5-HT3 receptors is reported in cocaine-conditioned rats, though 5-HT3's role is unclear.[194] The 5-HT2 receptor (particularly the subtypes 5-HT2A, 5-HT2B and 5-HT2C) are involved in the locomotor-activating effects of cocaine.[195]

Cocaine has been demonstrated to bind as to directly stabilize the DAT transporter on the open outward-facing conformation. Further, cocaine binds in such a way as to inhibit a hydrogen bond innate to DAT. Cocaine's binding properties are such that it attaches so this hydrogen bond will not form and is blocked from formation due to the tightly locked orientation of the cocaine molecule. Research studies have suggested that the affinity for the transporter is not what is involved in the habituation of the substance so much as the conformation and binding properties to where and how on the transporter the molecule binds.[196]

Conflicting findings have challenged the widely accepted view that cocaine functions solely as a reuptake inhibitor. To induce euphoria an intravenous dose of 0.3-0.6 mg/kg of cocaine is required, which blocks 66-70% of DAT in the brain.[197] Re-administering cocaine beyond this threshold does not significantly increase DAT occupancy but still results in an increase of euphoria which cannot be explained by reuptake inhibition alone. This discrepancy is not shared with other dopamine reuptake inhibitors like bupropion, sibutramine, mazindol or tesofensine, which have similar or higher potencies than cocaine as dopamine reuptake inhibitors. Furthermore, a similar response-occupancy discrepancy has been observed with methylphenidate, which also stabilizes the dopamine transporter in an open outward-facing conformation.[198][199][200] These findings have evoked a hypothesis that cocaine may also function as a so-called "DAT inverse agonist" or "negative allosteric modifier of DAT" resulting in dopamine transporter reversal, and subsequent dopamine release into the synaptic cleft from the axon terminal in a manner similar to but distinct from amphetamines.[198]

Sigma receptors are affected by cocaine, as cocaine functions as a sigma ligand agonist.[201] Further specific receptors it has been demonstrated to function on are NMDA and the D1 dopamine receptor.[202]

Cocaine also blocks sodium channels, thereby interfering with the propagation of action potentials;[203][95] thus, like lignocaine and novocaine, it acts as a local anesthetic. It also functions on the binding sites to the dopamine and serotonin sodium dependent transport area as targets as separate mechanisms from its reuptake of those transporters; unique to its local anesthetic value which makes it in a class of functionality different from both its own derived phenyltropanes analogues which have that removed. In addition to this, cocaine has some target binding to the site of the κ-opioid receptor.[204][unreliable medical source?] Cocaine also causes vasoconstriction, thus reducing bleeding during minor surgical procedures. Recent research points to an important role of circadian mechanisms[205] and clock genes[206] in behavioral actions of cocaine.

Cocaine is known to suppress hunger and appetite by increasing co-localization of sigma σ1R receptors and ghrelin GHS-R1a cell surface receptors, thereby increasing ghrelin-mediated signaling of satiety[207] and possibly via other effects on appetitive hormones.[208]

Cocaine effects, further, are shown to be potentiated for the user when used in conjunction with new surroundings and stimuli, and otherwise novel environs.[209]

Chemistry

[edit]

Forms

[edit]
A pile of micronized cocaine hydrochloride
A piece of compressed cocaine hydrochloride

In its purest form, cocaine is a white, pearly powder. As a tropane alkaloid, cocaine is a weak base and readily forms salts when combined with acids. The most commonly encountered form is the hydrochloride (HCl) salt, although other salts such as the sulfate (SO42−) and nitrate (NO3) are occasionally observed. The solubility of these salts varies depending on their polarity; the hydrochloride salt is polar and highly soluble in water.[210]

Synthesis

[edit]

Total synthesis

[edit]

The first structure elucidation and total synthesis of the cocaine molecule was accomplished by Richard Willstätter in 1898.[211] Willstätter’s synthesis involved constructing the cocaine structure from simpler precursors, notably via the intermediate tropinone. Subsequent significant contributions to understanding the synthetic pathway and stereochemistry were made by Robert Robinson and Edward Leete.

Cocaine contains four chiral centers (1R, 2R, 3S, and 5S), two of which are configurationally dependent, resulting in eight possible stereoisomers. The formation of inactive stereoisomers, along with various synthetic by-products, limits both the yield and purity of the final product.[212][213]

Although the chemical synthesis of cocaine is technically feasible, it is generally considered impractical due to its high cost, low efficiency, and challenges in stereoselective synthesis compared to extraction from natural plant sources. While domestic clandestine laboratories could theoretically reduce reliance on offshore production and international smuggling—as seen with illicit methamphetamine manufacture and synthetic production of cocaine remains rare. Large-scale commercial synthesis has not been explored.[34]

Biosynthesis

[edit]

The biosynthesis of cocaine is the natural metabolic process by which the coca plant (Erythroxylum species) produces cocaine, a tropane alkaloid, through a multi-step enzymatically catalyzed pathway beginning with ornithine or arginine and culminating in the formation of the cocaine metabolite benzoylecgonine.

The biosynthesis of cocaine has long attracted the attention of biochemists and organic chemists. This interest is partly motivated by the strong physiological effects of cocaine, but a further incentive was the unusual bicyclic structure of the molecule. The biosynthesis can be viewed as occurring in two phases, one phase leading to the N-methylpyrrolinium ring, which is preserved in the final product. The second phase incorporates a C4 unit with formation of the bicyclic tropane core.[214]

GMO synthesis

[edit]

In 2022, a GMO produced N. benthamiana were discovered that were able to produce 25% of the amount of cocaine found in a coca plant.[215]

However, since N. benthamiana also naturally contains nicotine, separating the cocaine from nicotine and related alkaloids would be challenging.

Field analysis

[edit]
Drugwipe test can detect traces of illicit substances, including cocaine, on surfaces such as driver's licenses at random checkpoints.
Cocaine under UV light

Personal cards-including ID cards and driver's licenses-are frequently swabbed by inspectors to detect drug residue, as these items are commonly used to prepare lines of cocaine. Swabbing can reveal traces of cocaine or other illicit substances, providing evidence of recent drug handling or use. This practice may be employed during security checks at border crossings.

A Newsbeat investigation found that "cocaine torches" used by UK police to detect cocaine use are ineffective on typical street cocaine, as independent lab tests showed they fail to make the drug fluoresce. Experts and drug charities criticized the devices, warning they can give false positives and waste resources, while police forces defended their use as a deterrent. The manufacturer says the torches only work on much purer forms of cocaine than are found on the street.[216][217]

Cocaine may be detected by law enforcement using the Scott reagent. The test can easily generate false positives for common substances and must be confirmed with a laboratory test.[218][219]

Approximate cocaine purity can be determined using 1 mL 2% cupric sulfate pentahydrate in dilute HCl, 1 mL 2% potassium thiocyanate and 2 mL of chloroform. The shade of brown shown by the chloroform is proportional to the cocaine content. This test is not cross sensitive to heroin, methamphetamine, benzocaine, procaine and a number of other drugs but other chemicals could cause false positives.[220]

Society and culture

[edit]

Large-scale chemical synthesis of cocaine is unexplored;[34] Both the pharmaceutical supply chain and the illicit supply chain obtain cocaine from coca cultivated almost exclusively in the Andean regions of Colombia, Peru, and Bolivia, which together account for nearly all global coca production, but they operate under very different controls and oversight. In Peru, for example, legal coca cultivation is monopolized by the state company National Coca Company (ENACO), yet approximately 90% of coca leaves produced in the country are diverted to illegal actors for cocaine manufacturing.[221] As a result, these illicit coca crops are a primary target of ongoing government-led coca eradication efforts.[222]

Street names

[edit]

Cocaine is sometimes referred to on the street as blow, coca, coke, crank, flake, snow, or soda cot. Slang terms for free base cocaine include crack or rock.[223]

[edit]
Legal status of cocaine possession

The production, distribution, and sale of cocaine products is restricted (and illegal in most contexts) in most countries as regulated by the Single Convention on Narcotic Drugs, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. In the United States the manufacture, importation, possession, and distribution of cocaine are additionally regulated by the 1970 Controlled Substances Act.

Some countries, such as Bolivia, Colombia, and Peru, permit the cultivation of coca leaf for traditional consumption by the local indigenous population, but nevertheless, prohibit the production, sale, and consumption of cocaine.[224] The provisions as to how much a coca farmer can yield annually is protected by laws such as the Bolivian Cato accord.[225] In addition, some parts of Europe, the United States, and Australia allow processed cocaine for medicinal uses only.

Australia

[edit]

Cocaine is a Schedule 8 controlled drug in Australia under the Poisons Standard.[226] It is the second most popular illicit recreational drug in Australia behind cannabis.[227]

In Western Australia under the Misuse of Drugs Act 1981 4.0g of cocaine is the amount of prohibited drugs determining a court of trial, 2.0g is the amount of cocaine required for the presumption of intention to sell or supply and 28.0g is the amount of cocaine required for purposes of drug trafficking.[228]

United States

[edit]
President George H. W. Bush holds up a bag of crack cocaine during his Address to the Nation on National Drug Control Strategy on September 5, 1989.

The US federal government instituted a national drug labelling requirement for cocaine and cocaine-containing products through the Pure Food and Drug Act of 1906.[229]: 37  The next important federal regulation was the Harrison Narcotics Tax Act of 1914. While this act is often seen as the start of prohibition, the act itself was not actually a prohibition on cocaine, but instead set up a regulatory and licensing regime.[230] The Harrison Act did not recognize addiction as a treatable condition and therefore the therapeutic use of cocaine, heroin, or morphine to such individuals was outlawed – leading a 1915 editorial in the journal American Medicine to remark that the addict "is denied the medical care he urgently needs, open, above-board sources from which he formerly obtained his drug supply are closed to him, and he is driven to the underworld where he can get his drug, but of course, surreptitiously and in violation of the law."[231] The Harrison Act left manufacturers of cocaine untouched so long as they met certain purity and labeling standards.[229]: 40  Despite that cocaine was typically illegal to sell and legal outlets were rarer, the quantities of legal cocaine produced declined very little.[229]: 40  Legal cocaine quantities did not decrease until the Jones–Miller Act of 1922 put serious restrictions on cocaine manufactures.[229]: 40 

Before the early 1900s, newspapers primarily portrayed addiction-not violence or crime-as the main problem caused by cocaine use, and depicted cocaine users as upper or middle class White people. In 1914, The New York Times published an article titled "Negro Cocaine 'Fiends' Are a New Southern Menace," portraying Black people who used cocaine as dangerous and able to withstand wounds that would normally be fatal.[232] The Anti-Drug Abuse Act of 1986 mandated the same prison sentences for distributing 500 grams of powdered cocaine and just 5 grams of crack cocaine.[233] In the National Survey on Drug Use and Health, white respondents reported a higher rate of powdered cocaine use, and Black respondents reported a higher rate of crack cocaine use.[234]

[edit]

Cocaine production, seizures, and use all reached record levels in 2023, making it the world’s fastest-growing illicit drug market. Seizures rose by 68% from 2019 to 2023, while the number of users increased from 17 million in 2013 to 25 million in 2023, according to the UNODC World Drug Report 2025.[235]

The report further states that Western Europe’s cocaine market is rapidly expanding, resulting in increased violence driven by traffickers, including organized criminal groups from the Western Balkans. Concurrently, record levels of cocaine production have enabled traffickers to enter new markets across Asia and Africa, reflecting the expanding global reach of cocaine trafficking.[236]

The U.S. is the world's largest consumer of cocaine,[237] while South America ranks third.[18]

Cocaine is among the most widely consumed recreational stimulants worldwide.[23]

Impact of illicit cocaine trade

[edit]

Latin America

[edit]

Drug war policies in Latin America and the Caribbean have led to more violence, higher incarceration rates, health crises, and deeper poverty, while undermining trust in institutions and worsening inequality. There is increasing support for shifting toward drug policies that focus on sustainable development and human rights instead of punitive measures.[238]

Research

[edit]

Cocaine haptens are chemically modified derivatives of cocaine that retain key immunogenic features, allowing them to be attached to carrier proteins such as keyhole limpet hemocyanin or bovine serum albumin. This enables the immune system to recognize cocaine and produce anti-cocaine antibodies, which can bind cocaine in the bloodstream and prevent it from reaching the brain, thereby blocking its psychoactive effects.[239][240][241]

Coca tea has been explored as a supportive treatment for cocaine dependence. A study in Lima, Peru, found that using coca leaf infusion along with counseling reduced relapse rates and significantly increased the duration of abstinence among addicted individuals, suggesting that this approach may help prevent relapse during treatment.[242]

Recent research has also examined the use of prescription psychostimulants for cocaine dependence, following the Self-Medication Hypothesis. This hypothesis suggests that some individuals use cocaine to address underlying neurochemical or psychological issues. While some studies indicate that psychostimulant therapy may reduce cocaine use and cravings, the evidence is mixed and further research is needed.[243]

In animal studies, nicotine exposure in mice increases the likelihood of later cocaine use, with clear molecular changes in the brain.[244] These findings mirror human epidemiological data showing a link between nicotine use and increased risk of later cannabis and cocaine use, as well as other substances.[245][246] Similarly, in rats, alcohol consumption raises the probability of later cocaine addiction and is associated with changes in the brain’s reward system.[247][248] Human studies also show that alcohol use increases the risk of transitioning from cocaine use to addiction.[249][250]

Experimentally, cocaine injections can be delivered to animals such as fruit flies to study the mechanisms of cocaine addiction.[251]

TA-CD

[edit]

TA-CD is a vaccine developed by the Xenova Group and designed to negate the effects of cocaine, making it suitable for use in treatment of addiction. It is created by combining norcocaine with inactivated cholera toxin.[252]

History

[edit]

Coca leaves have been used by indigenous South Americans for thousands of years, both as a stimulant and for medicinal purposes.[253] When the Spanish arrived in South America, they initially banned coca but soon legalized and taxed it after seeing its importance to local labor.[254] The active ingredient, cocaine, was first isolated in 1855 by Friedrich Gaedcke and later refined by Albert Niemann, who named it “cocaine.”[255][256][257] In the late 1800s, cocaine became popular in Western medicine as a local anesthetic and was widely used in various products, including drinks and remedies.[258] and James Leonard Corning demonstrated peridural anesthesia.[259] However, due to its toxic effects and potential for abuse, safer alternatives eventually replaced it in medical practice.[19]

Etymology

[edit]

The word cocaine derives from French Cocaïne, from Spanish coca, ultimately from Quechua kúka.[260]

See also

[edit]

References

[edit]
  1. ^ Nordegren T (2002). The A-Z Encyclopedia of Alcohol and Drug Abuse. Universal-Publishers. p. 461. ISBN 978-1-58112-404-0. Archived from the original on 8 July 2024. Retrieved 3 September 2020.
  2. ^ a b c "Goprelto – cocaine hydrochloride solution". DailyMed. 3 January 2020. Archived from the original on 30 July 2020. Retrieved 30 April 2020.
  3. ^ a b c "Numbrino – cocaine hydrochloride nasal solution". DailyMed. 28 February 2020. Archived from the original on 30 July 2020. Retrieved 30 April 2020.
  4. ^ Ghodse H (2010). Ghodse's Drugs and Addictive Behaviour: A Guide to Treatment (4 ed.). Cambridge University Press. p. 91. ISBN 978-1-139-48567-8. Archived from the original on 10 September 2017.
  5. ^ Introduction to Pharmacology (3 ed.). Abingdon: CRC Press. 2007. pp. 222–223. ISBN 978-1-4200-4742-4. Archived from the original on 10 September 2017.
  6. ^ a b Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, et al. (April 2001). "Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference". Proceedings of the National Academy of Sciences of the United States of America. 98 (9): 5300–5305. Bibcode:2001PNAS...98.5300S. doi:10.1073/pnas.091039298. PMC 33204. PMID 11320258.
  7. ^ a b c d Azizi SA (April 2022). "Monoamines: Dopamine, Norepinephrine, and Serotonin, Beyond Modulation, "Switches" That Alter the State of Target Networks". The Neuroscientist. 28 (2): 121–143. doi:10.1177/1073858420974336. PMID 33292070. S2CID 228080727.
  8. ^ "DEA / Drug Scheduling". www.dea.gov. Archived from the original on 9 August 2017. Retrieved 7 August 2017.
  9. ^ a b Fattinger K, Benowitz NL, Jones RT, Verotta D (July 2000). "Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine". European Journal of Clinical Pharmacology. 56 (4): 305–10. doi:10.1007/s002280000147. PMID 10954344. S2CID 20708443.
  10. ^ Barnett G, Hawks R, Resnick R (1981). "Cocaine pharmacokinetics in humans". Journal of Ethnopharmacology. 3 (2–3): 353–66. doi:10.1016/0378-8741(81)90063-5. PMID 7242115.
  11. ^ Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE (1989). "Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking". Drug Metabolism and Disposition. 17 (2): 153–9. doi:10.1016/S0090-9556(25)08737-9. PMID 2565204.
  12. ^ a b Wilkinson P, Van Dyke C, Jatlow P, Barash P, Byck R (March 1980). "Intranasal and oral cocaine kinetics". Clinical Pharmacology and Therapeutics. 27 (3): 386–94. doi:10.1038/clpt.1980.52. PMID 7357795. S2CID 29851205.
  13. ^ a b c d e f g h i j k l Zimmerman JL (October 2012). "Cocaine intoxication". Critical Care Clinics. 28 (4): 517–26. doi:10.1016/j.ccc.2012.07.003. PMID 22998988.
  14. ^ a b "Cocaine and crack drug profile | www.euda.europa.eu". www.euda.europa.eu.
  15. ^ "Cocaine - Alcohol and Drug Foundation". adf.org.au.
  16. ^ "The identification of coca (Erythroxylum species)". Botanical Journal of the Linnean Society. doi:10.1111/j.1095-8339.1982.tb00368.x.
  17. ^ a b c d e Pomara C, Cassano T, D'Errico S, Bello S, Romano AD, Riezzo I, et al. (2012). "Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers". Current Medicinal Chemistry. 19 (33): 5647–57. doi:10.2174/092986712803988811. PMID 22856655.
  18. ^ a b c "Coca Cultivation in the Andean Region" (PDF). UNODC. June 2006.
  19. ^ a b c Latorre F, Klimek L (January 1999). "Does cocaine still have a role in nasal surgery?". Drug Safety. 20 (1): 9–13. doi:10.2165/00002018-199920010-00002. PMID 9935273. S2CID 40598106.
  20. ^ a b c Armbuster YC, Banas BN, Feickert KD, England SE, Moyer EJ, Christie EL, et al. (December 2021). "Decline and Pronounced Regional Disparities in Medical Cocaine Usage in the United States". The Journal of Pharmacy Technology. 37 (6): 278–285. doi:10.1177/87551225211035563. PMC 8592245. PMID 34790964.
  21. ^ Cortés E, Metaal P. Smokable cocaine markets in Latin America and the Caribbean (PDF).
  22. ^ a b Cheng MH, Block E, Hu F, Cobanoglu MC, Sorkin A, Bahar I (2015). "Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding". Frontiers in Neurology. 6: 134. doi:10.3389/fneur.2015.00134. PMC 4460958. PMID 26106364.
  23. ^ a b Roque Bravo R, Faria AC, Brito-da-Costa AM, Carmo H, Mladěnka P, Dias da Silva D, et al. (April 2022). "Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern". Toxins. 14 (4): 278. doi:10.3390/toxins14040278. PMC 9032145. PMID 35448887.
  24. ^ Sordo L, Indave BI, Barrio G, Degenhardt L, de la Fuente L, Bravo MJ (September 2014). "Cocaine use and risk of stroke: a systematic review". Drug Alcohol Depend. 142: 1–13. doi:10.1016/j.drugalcdep.2014.06.041. PMID 25066468.
  25. ^ a b Buckingham-Howes S, Berger SS, Scaletti LA, Black MM (2013). "Systematic Review of Prenatal Cocaine Exposure and Adolescent Development". Pediatrics. 131 (6): e1917 – e1936. doi:10.1542/peds.2012-0945. PMC 3666107. PMID 23713107.
  26. ^ a b Lambert B, Bauer C (November 2012). "Developmental and behavioral consequences of prenatal cocaine exposure: a review". Journal of Perinatology : Official Journal of the California Perinatal Association. 32 (11): 819–828. doi:10.1038/jp.2012.90. PMC 4143247. PMID 22791278.
  27. ^ a b McCarthy DM, Kabir ZD, Bhide PG, Kosofsky BE (2014). "Effects of prenatal exposure to cocaine on brain structure and function". Progress in Brain Research. Vol. 211. pp. 277–289. doi:10.1016/B978-0-444-63425-2.00012-X. ISBN 978-0-444-63425-2. PMID 24968785.
  28. ^ a b Eiden RD, McAuliffe S, Kachadourian L, Coles C, Colder C, Schuetze P (January 2009). "Effects of prenatal cocaine exposure on infant reactivity and regulation". Neurotoxicology and Teratology. 31 (1): 60–68. Bibcode:2009NTxT...31...60E. doi:10.1016/j.ntt.2008.08.005. PMC 2631277. PMID 18822371.
  29. ^ a b Gawin FH, Ellinwood EH (1989). "Cocaine dependence". Annual Review of Medicine. 40: 149–61. doi:10.1146/annurev.me.40.020189.001053. PMID 2658744.
  30. ^ a b Sofuoglu M, Dudish-Poulsen S, Poling J, Mooney M, Hatsukami DK (July 2005). "The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users". Addictive Behaviors. 30 (6): 1125–1134. doi:10.1016/j.addbeh.2004.10.010. PMID 15925122.
  31. ^ a b Berberi A, Azar E (2024). "Oral Rehabilitation for a Patient with Cocaine-Induced Midline Destructive Lesions". Case Reports in Otolaryngology. 2024: 7109261. doi:10.1155/2024/7109261. PMC 11208820. PMID 38939732.
  32. ^ a b Nitro L, Pipolo C, Fadda GL, Allevi F, Borgione M, Cavallo G, et al. (July 2022). "Distribution of cocaine-induced midline destructive lesions: systematic review and classification". European Archives of Oto-Rhino-Laryngology. 279 (7): 3257–3267. doi:10.1007/s00405-022-07290-1. PMC 9130192. PMID 35138441.
  33. ^ a b c d Di Cosola M, Ambrosino M, Limongelli L, Favia G, Santarelli A, Cortelazzi R, et al. (July 2021). "Cocaine-Induced Midline Destructive Lesions (CIMDL): A Real Challenge in Diagnosis". International Journal of Environmental Research and Public Health. 18 (15): 7831. doi:10.3390/ijerph18157831. PMC 8345435. PMID 34360121.
  34. ^ a b c Kohnen-Johannsen KL, Kayser O (February 2019). "Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and Production". Molecules. 24 (4): 796. doi:10.3390/molecules24040796. PMC 6412926. PMID 30813289.
  35. ^ Murillo-Sandoval PJ, Sesnie SE, Ordoñez Armas ME, Magliocca N, Tellman B, Devine JA, et al. (1 October 2024). "Central America's agro-ecological suitability for cultivating coca, Erythroxylum spp". Environmental Research Letters. 19 (10): 104068. Bibcode:2024ERL....19j4068M. doi:10.1088/1748-9326/ad7276.
  36. ^ "Plantaciones, laboratorios y narcorutas de coca en Honduras". www.elheraldo.hn (in Spanish).
  37. ^ Papadovassilakis A, Voss G (10 February 2023). "Guatemala registra récord en producción de coca, pero no de cocaína". InSight Crime (in European Spanish).
  38. ^ "Police find half a million coca plants in Southern Belize". Belize News and Opinion on www.breakingbelizenews.com. 31 August 2023.
  39. ^ Housego K (5 April 2004). "As addiction rises, Colombia weighs rolling back decade-old drug legalization". The San Diego Union-Tribune. Associated Press. Retrieved 9 August 2009.
  40. ^ Murphy J (5 April 2004). "Colombia sinks in sea of legal cocaine, heroin". CBS News. Archived from the original on 5 April 2004. Retrieved 9 August 2009.
  41. ^ "Heroin and cocaine now legal in Mexico – in small doses | Americas | News | The Independent". The Independent. 23 October 2011. Retrieved 15 May 2016.
  42. ^ Greenwald G, Reuter P, Lynch T (3 April 2009). "Lessons for Creating Fair and Successful Drug Policies" (PDF). Drug Decriminalization in Portugal. Cato Institute.
  43. ^ a b Goldstein RA, DesLauriers C, Burda AM (January 2009). "Cocaine: history, social implications, and toxicity--a review". Disease-a-Month. 55 (1): 6–38. doi:10.1016/j.disamonth.2008.10.002. PMID 19081448.
  44. ^ Valdez LM, Taboada J, Valdez JE (June 2015). "Ancient Use of Coca Leaves in the Peruvian Central Highlands". Journal of Anthropological Research. 71 (2): 231–258. doi:10.3998/jar.0521004.0071.204. hdl:2027/spo.0521004.0071.204. S2CID 163842955.
  45. ^ Martin RT (October 1970). "The role of coca in the history, religion, and medicine of South American Indians". Economic Botany. 24 (4): 422–438. Bibcode:1970EcBot..24..422M. doi:10.1007/BF02860746. S2CID 34523519.
  46. ^ Plant T, Aref-Adib G (June 2008). "Travelling to new heights: practical high altitude medicine". British Journal of Hospital Medicine. 69 (6): 348–352. doi:10.12968/hmed.2008.69.6.29626. PMID 18646420.
  47. ^ Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, Schoene RB, et al. (December 2014). "Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update". Wilderness & Environmental Medicine. 25 (4 Suppl): S4–14. doi:10.1016/j.wem.2014.06.017. PMID 25498261.
  48. ^ World Drug Report 2021: Booklet 4 (PDF). [S.l.]: United Nations Office on Drugs and Crime. 2021. p. 35. ISBN 978-92-1-148361-1. Archived (PDF) from the original on 24 June 2021.
  49. ^ Room R, Reuter P (January 2012). "How well do international drug conventions protect public health?". Lancet. 379 (9810): 84–91. doi:10.1016/s0140-6736(11)61423-2. PMID 22225673. S2CID 23386203. The international treaties have also constrained national policy experimentation because they require nation states to criminalise drug use
  50. ^ "Drug Fact Sheet: Cocaine" (PDF). Drug Enforcement Agency. Archived (PDF) from the original on 21 June 2020. Retrieved 17 June 2022.
  51. ^ "Drug Fact Sheet: Cocaine" (PDF). US Department for Justice and Drug Enforcement Administration. Archived (PDF) from the original on 21 June 2020. Retrieved 29 June 2024.
  52. ^ "The tradition of chewing coca". 15 August 2013. Archived from the original on 6 May 2021. Retrieved 6 May 2021.
  53. ^ Embury-Dennis T. "It's legal to manufacture cocaine and heroin for medical use — and Britain is the world's biggest exporter". Business Insider. Archived from the original on 28 July 2020. Retrieved 17 March 2019.
  54. ^ "Cocaine: Effects, Hazards & Warnings". Drugs.com. Archived from the original on 28 July 2020. Retrieved 17 March 2019.
  55. ^ Siegel RK, Elsohly MA, Plowman T, Rury PM, Jones RT (January 1986). "Cocaine in herbal tea". JAMA. 255 (1): 40. doi:10.1001/jama.1986.03370010042021. PMID 3940302.
  56. ^ Schultes RE (1957). "A New Method of Coca Preparation in the Colombian Amazon". Botanical Museum Leaflets, Harvard University. 17 (9): 241–246. doi:10.5962/p.168505. ISSN 0006-8098. JSTOR 41762172.
  57. ^ Dwyer C, Sowerby L, Rotenberg BW (August 2016). "Is cocaine a safe topical agent for use during endoscopic sinus surgery?". The Laryngoscope (Review). 126 (8): 1721–1723. doi:10.1002/lary.25836. PMID 27075241.
  58. ^ Benjamin E, Wong DK, Choa D (December 2004). "'Moffett's' solution: a review of the evidence and scientific basis for the topical preparation of the nose". Clinical Otolaryngology and Allied Sciences. 29 (6): 582–587. doi:10.1111/j.1365-2273.2004.00894.x. PMID 15533141.
  59. ^ Hamdan AL, Sataloff RT, Hawkshaw MJ (2022). "Topical Anesthesia in Office-Based Laryngeal Surgery". Office-Based Laryngeal Surgery. USA: Springer. pp. 123–137. doi:10.1007/978-3-030-91936-8_6. ISBN 978-3-030-91935-1. Archived from the original on 18 July 2022. Retrieved 18 July 2022.
  60. ^ "Drug Approval Package: Goprelto (cocaine hydrochloride)". U.S. Food and Drug Administration (FDA). 30 April 2018. Archived from the original on 28 July 2020. Retrieved 30 April 2020.
  61. ^ Public Domain This article incorporates text from this source, which is in the public domain: "Numbrino: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 28 July 2020. Retrieved 30 April 2020.
  62. ^ Berkowitz AL (2022). "Chapter 10: Pupillary Control & Approach to Anisocoria: Cranial Nerves 2 & 3". Clinical Neurology & Neuroanatomy: A Localization-Based Approach (Digital) (2nd ed.). McGraw Hill. ISBN 978-1260453362.
  63. ^ a b World Health Organization (2004). Neuroscience of psychoactive substance use and dependence. World Health Organization. p. 89. ISBN 978-9241562355. Archived from the original on 30 April 2016.
  64. ^ World Health Organization (2007). International medical guide for ships. World Health Organization. p. 242. ISBN 978-9241547208. Archived from the original on 30 April 2016.
  65. ^ a b Sordo L, Indave BI, Barrio G, Degenhardt L, de la Fuente L, Bravo MJ (September 2014). "Cocaine use and risk of stroke: a systematic review". Drug and Alcohol Dependence (Systematic Review). 142: 1–13. doi:10.1016/j.drugalcdep.2014.06.041. PMID 25066468.
  66. ^ Donroe JH, Tetrault JM (July 2017). "Substance Use, Intoxication, and Withdrawal in the Critical Care Setting". Critical Care Clinics (Review). 33 (3): 543–558. doi:10.1016/j.ccc.2017.03.003. PMID 28601134.
  67. ^ Fehrman E, Egan V, Gorban AN, Levesley J, Mirkes EM, Muhammad AK (2019). Personality Traits and Drug Consumption. A Story Told by Data. Springer, Cham. arXiv:2001.06520. doi:10.1007/978-3-030-10442-9. ISBN 978-3-030-10441-2. S2CID 151160405.
  68. ^ "Patients face losing noses due to cocaine use, medics warn". 9 March 2023.
  69. ^ Veevers L (1 October 2006). "'Shared banknote' health warning to cocaine users". The Observer. Retrieved 26 July 2008.
  70. ^ "DrugFacts: Cocaine". National Institute on Drug Abuse. April 2013. Archived from the original on 11 July 2015. Retrieved 11 July 2015.
  71. ^ "The Dangers Of Snorting Cocaine (Insufflation)". Vertava Health. Archived from the original on 8 April 2022. Retrieved 25 February 2022.
  72. ^ a b Volkow ND, Wang GJ, Fischman MW, Foltin R, Fowler JS, Franceschi D, et al. (August 2000). "Effects of route of administration on cocaine-induced dopamine transporter blockade in the human brain". Life Sciences. 67 (12): 1507–1515. doi:10.1016/S0024-3205(00)00731-1. PMID 10983846.
  73. ^ "Drug Money". Snopes. 9 July 2002. Retrieved 23 July 2008.
  74. ^ Abrahamson A (13 November 1994). "Prevalence of Drug-Tainted Money Voids Case Law: Court cites findings that more than 75% of currency in L.A. bears traces of cocaine or other illegal substances". Los Angeles Times. Archived from the original on 4 June 2011. Retrieved 23 July 2008.
  75. ^ Price DM (6 May 1990). "Use of Drug-Sniffing Dogs Challenged;ACLU Backs Complaint by Men Whose Pocket Cash Was Seized". The Washington Post. Archived from the original on 4 June 2011. Retrieved 23 July 2008.
  76. ^ "Sniffing Around the History of the McDonald's 'Cocaine Spoon'". www.mentalfloss.com. 19 March 2021. Archived from the original on 8 July 2024. Retrieved 14 June 2021.
  77. ^ "Cocaine terminology". Archived from the original on 9 July 2007.
  78. ^ Bonkovsky HL, Mehta S (February 2001). "Hepatitis C: a review and update". Journal of the American Academy of Dermatology. 44 (2): 159–182. doi:10.1067/mjd.2001.109311. PMID 11174373.
  79. ^ "Code of ordinances village of Dundee, Michigan. Chapter 51". Village of Dundee.
  80. ^ "Code of Ordinances – Clark County, NV". Municode Library. Archived from the original on 13 September 2024. Retrieved 13 September 2024.
  81. ^ "Township of Middlesex, PA Drugs and Drug Paraphernalia". eCode360. Archived from the original on 13 September 2024. Retrieved 13 September 2024.
  82. ^ Graybosch AJ (1 January 2004). "American Beauty". Deconstruction and Reconstruction. Brill. p. 96. doi:10.1163/9789004495876_013. ISBN 978-90-420-1681-1.
  83. ^ Ries RK, Miller SC, Fiellin DA (2009). Principles of addiction medicine. Lippincott Williams & Wilkins. p. 137. ISBN 978-0-7817-7477-2. Archived from the original on 4 April 2014. Retrieved 5 January 2014.
  84. ^ a b Richards JR, Laurin EG (June 2023). "Cocaine". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 28613520.
  85. ^ a b c d "Cocaine as a Teratogen". Embryo Project Encyclopedia. Arizona State University. Retrieved 7 April 2025.
  86. ^ Singer L, Arendt R, Minnes S (March 1993). "Neurodevelopmental effects of cocaine". Clinics in Perinatology. 20 (1): 245–262. doi:10.1016/S0095-5108(18)30422-6. PMC 4181371. PMID 8458168.
  87. ^ Cain MA, Bornick P, Whiteman V (March 2013). "The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy". Clinical Obstetrics and Gynecology. 56 (1): 124–132. doi:10.1097/GRF.0b013e31827ae167. PMID 23314714.
  88. ^ Flowers D, Clark JF, Westney LS (March 1991). "Cocaine intoxication associated with abruptio placentae". Journal of the National Medical Association. 83 (3): 230–232. PMC 2627035. PMID 2038082.
  89. ^ "When breastfeeding or feeding expressed milk is not recommended". Centers for Disease Control and Prevention. 10 August 2021. Retrieved 14 November 2021.
  90. ^ Eglash A, Leeper K (2020). The Little Green Book of Breastfeeding Management for Physicians & Other Healthcare Providers (7 ed.). Madison, WI: The Institute for the Advancement of Breastfeeding and Lactation Education. ISBN 978-0-9987789-0-7.
  91. ^ "Street Drugs and pregnancy". March of Dimes. Archived from the original on 5 September 2015. Retrieved 26 May 2009.
  92. ^ Nutt DJ, King LA, Phillips LD (November 2010). "Drug harms in the UK: a multicriteria decision analysis". Lancet. 376 (9752): 1558–65. CiteSeerX 10.1.1.690.1283. doi:10.1016/S0140-6736(10)61462-6. PMID 21036393. S2CID 5667719.
  93. ^ Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". Lancet. 369 (9566): 1047–53. doi:10.1016/S0140-6736(07)60464-4. PMID 17382831. S2CID 5903121.
  94. ^ Talarico GP, Crosta ML, Giannico MB, Summaria F, Calò L, Patrizi R (May 2017). "Cocaine and coronary artery diseases: a systematic review of the literature". Journal of Cardiovascular Medicine. 18 (5): 291–294. doi:10.2459/JCM.0000000000000511. PMID 28306693.
  95. ^ a b c d O'Leary ME, Hancox JC (May 2010). "Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias". British Journal of Clinical Pharmacology. 69 (5): 427–42. doi:10.1111/j.1365-2125.2010.03629.x. PMC 2856043. PMID 20573078.
  96. ^ Vonmoos M, Hirsiger S, Preller KH, Hulka LM, Allemann D, Herdener M, et al. (October 2018). "Cognitive and neuroanatomical impairments associated with chronic exposure to levamisole-contaminated cocaine". Translational Psychiatry. 8 (1): 235. doi:10.1038/s41398-018-0279-3. PMC 6204136. PMID 30368522.
  97. ^ Buchanan JA, Oyer RJ, Patel NR, Jacquet GA, Bornikova L, Thienelt C, et al. (June 2010). "A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole". Journal of Medical Toxicology. 6 (2): 160–164. doi:10.1007/s13181-010-0060-3. PMC 3550277. PMID 20358411.
  98. ^ "2017 National Drug Threat Assessment" (PDF). Drug Enforcement Administration. 1 October 2017. Retrieved 17 June 2025.
  99. ^ Solomon N, Hayes J (September 2017). "Levamisole: A High Performance Cutting Agent". Academic Forensic Pathology. 7 (3): 469–476. doi:10.23907/2017.039. PMC 6474566. PMID 31239995.
  100. ^ a b Gill H, Trinh D, Anderson DJ, Li N, Madenberg D (August 2021). "Cocaine and Levamisole Induced Vasculitis". Cureus. 13 (8): e17192. doi:10.7759/cureus.17192. PMC 8439268. PMID 34548986.
  101. ^ a b Cascio MJ, Jen KY (January 2018). "Cocaine/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity". Current Opinion in Hematology. 25 (1): 29–36. doi:10.1097/MOH.0000000000000393. PMID 29211697.
  102. ^ "How to Test Your Drugs With Reagents" (PDF). DanceSafe.
  103. ^ Fredericks C, Yon JR, Alex G, Morton M, Messer T, Bokhari F, et al. (March 2017). "Levamisole-induced Necrosis Syndrome: Presentation and Management". Wounds. 29 (3): 71–76. PMID 28355139.
  104. ^ Morris GW, Mason BC, Harris Sprunger R, Hake Harris H, White LA, Patterson DA (2012). "Levamisole-adulterated cocaine: a case series". Journal of the American Board of Family Medicine. 25 (4): 531–535. doi:10.3122/jabfm.2012.04.110287. PMID 22773722.
  105. ^ Lee KC, Ladizinski B, Federman DG (June 2012). "Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge". Mayo Clinic Proceedings. 87 (6): 581–586. doi:10.1016/j.mayocp.2012.03.010. PMC 3498128. PMID 22677078.
  106. ^ "Cocaine retail markets: multiple indicators suggest continued growth and diversification | www.euda.europa.eu". www.euda.europa.eu.
  107. ^ Chang A, Osterloh J, Thomas J (September 2010). "Levamisole: a dangerous new cocaine adulterant". Clinical Pharmacology and Therapeutics. 88 (3): 408–411. doi:10.1038/clpt.2010.156. PMID 20668440. S2CID 31414939.
  108. ^ Tallarida CS, Egan E, Alejo GD, Raffa R, Tallarida RJ, Rawls SM (April 2014). "Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo". Neuropharmacology. 79: 590–595. doi:10.1016/j.neuropharm.2014.01.002. PMC 3989204. PMID 24440755.
  109. ^ Chang A, Osterloh J, Thomas J (September 2010). "Levamisole: a dangerous new cocaine adulterant". Clinical Pharmacology and Therapeutics. 88 (3): 408–411. doi:10.1038/clpt.2010.156. PMID 20668440. S2CID 31414939.
  110. ^ "697. Levamisole (WHO Food Additives Series 27)". www.inchem.org.
  111. ^ Iorio L, Davanzo F, Cazzador D, Codirenzi M, Fiorin E, Zanatta E, et al. (August 2024). "Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune Manifestations". Journal of Clinical Medicine. 13 (17): 5116. doi:10.3390/jcm13175116. PMC 11396482. PMID 39274328.
  112. ^ Cascio MJ, Jen KY (January 2018). "Cocaine/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity". Current Opinion in Hematology. 25 (1): 29–36. doi:10.1097/MOH.0000000000000393. PMID 29211697. S2CID 23795272.
  113. ^ Peacock A, Tran LT, Larney S, Stockings E, Santo T, Jones H, et al. (April 2021). "All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis". Addiction. 116 (4): 725–742. doi:10.1111/add.15239. PMC 7914269. PMID 32857457.
  114. ^ "Cocaine or alcohol, what's worse?". Liberty House Clinic. 17 February 2025. Retrieved 19 April 2025.
  115. ^ a b Clare K, Park K, Pan Y, Lejuez CW, Volkow ND, Du C (2024). "Neurovascular effects of cocaine: relevance to addiction". Frontiers in Pharmacology. 15: 1357422. doi:10.3389/fphar.2024.1357422. PMC 10917943. PMID 38455961.
  116. ^ Nicolucci C, Pais ML, Santos AC, Ribeiro FM, Encarnação PM, Silva AL, et al. (2020). "Single Low Dose of Cocaine-Structural Brain Injury Without Metabolic and Behavioral Changes". Frontiers in Neuroscience. 14: 589897. doi:10.3389/fnins.2020.589897. PMC 7874143. PMID 33584173.
  117. ^ Hofmaier T, Luf A, Seddik A, Stockner T, Holy M, Freissmuth M, et al. (July 2014). "Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters". Neurochemistry International. 73 (100): 32–41. doi:10.1016/j.neuint.2013.11.010. PMC 4077236. PMID 24296074.
  118. ^ Brady KT, Lydiard RB, Malcolm R, Ballenger JC (December 1991). "Cocaine-induced psychosis". The Journal of Clinical Psychiatry. 52 (12): 509–512. PMID 1752853.
  119. ^ a b c Thirthalli J, Benegal V (May 2006). "Psychosis among substance users". Current Opinion in Psychiatry. 19 (3): 239–245. doi:10.1097/01.yco.0000218593.08313.fd. PMID 16612208. S2CID 13350537.
  120. ^ Elliott A, Mahmood T, Smalligan RD (2012). "Cocaine bugs: a case report of cocaine-induced delusions of parasitosis". The American Journal on Addictions. 21 (2): 180–181. doi:10.1111/j.1521-0391.2011.00208.x. PMID 22332864.
  121. ^ DiSclafani II A, Hall RC, Gardner ER (October 1981). "Drug-induced psychosis: emergency diagnosis and management". Psychosomatics. 22 (10): 845–50, 855. doi:10.1016/s0033-3182(81)73092-5. PMID 7313045.
  122. ^ Heesch CM, Negus BH, Keffer JH, Snyder RW, Risser RC, Eichhorn EJ (August 1995). "Effects of cocaine on cortisol secretion in humans". The American Journal of the Medical Sciences. 310 (2): 61–4. doi:10.1097/00000441-199508000-00004. PMID 7631644. S2CID 11042810.
  123. ^ a b Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin SG, Atkinson AJ (July 1988). "Acute tolerance to cocaine in humans". Clinical Pharmacology and Therapeutics. 44 (1): 1–8. doi:10.1038/clpt.1988.104. PMID 3390996. S2CID 44253676.
  124. ^ Pudiak CM, KuoLee R, Bozarth MA (July 2014). "Tolerance to cocaine in brain stimulation reward following continuous cocaine infusions". Pharmacology, Biochemistry, and Behavior. 122: 246–52. doi:10.1016/j.pbb.2014.04.006. PMID 24768900. S2CID 207332822.
  125. ^ Gullapalli BT, Natarajan A, Angarita GA, Malison RT, Ganesan D, Rahman T (21 June 2019). "On-body Sensing of Cocaine Craving, Euphoria and Drug-Seeking Behavior Using Cardiac and Respiratory Signals". Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies. 3 (2): 1–31. doi:10.1145/3328917. S2CID 195357215.
  126. ^ Calipari ES, Ferris MJ, Jones SR (January 2014). "Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine". Journal of Neurochemistry. 128 (2): 224–32. doi:10.1111/jnc.12452. PMC 3947316. PMID 24102293.
  127. ^ a b Zhao W (2008). Mechanisms Mediating Sex Differences in the Effects of Cocaine. University of Michigan. p. 3. ISBN 978-0-549-99458-9. Archived from the original on 4 April 2014. Retrieved 25 September 2012.
  128. ^ Boles SM, Miotto K (March–April 2003). "Substance abuse and violence: A review of the literature". Aggression and Violent Behavior. 8 (2): 155–174. doi:10.1016/S1359-1789(01)00057-X.
  129. ^ Pergolizzi JV, Magnusson P, LeQuang JA, Breve F, Varrassi G (April 2021). "Cocaine and Cardiotoxicity: A Literature Review". Cureus. 13 (4): e14594. doi:10.7759/cureus.14594. ISSN 2168-8184. PMC 8136464. PMID 34036012.
  130. ^ a b Treadwell SD, Robinson TG (June 2007). "Cocaine use and stroke". Postgraduate Medical Journal. 83 (980): 389–394. doi:10.1136/pgmj.2006.055970. PMC 2600058. PMID 17551070.
  131. ^ Havakuk O, Rezkalla SH, Kloner RA (July 2017). "The Cardiovascular Effects of Cocaine". Journal of the American College of Cardiology (Review). 70 (1): 101–113. doi:10.1016/j.jacc.2017.05.014. PMID 28662796.
  132. ^ Frazer KM, Richards Q, Keith DR (August 2018). "The long-term effects of cocaine use on cognitive functioning: A systematic critical review". Behavioural Brain Research. 348: 241–262. doi:10.1016/j.bbr.2018.04.005. PMID 29673580. S2CID 4992738.
  133. ^ D'haenen H, den Boer JA, Willner P, eds. (2002). Biological Psychiatry. Vol. 2 (2 ed.). Wiley. p. 528. ISBN 978-0-471-49198-9.
  134. ^ Wang GJ, Volkow ND, Fowler JS, Fischman M, Foltin R, Abumrad NN, et al. (8 August 1997). "Cocaine abusers do not show loss of dopamine transporters with age". Life Sciences. 61 (11): 1059–65. doi:10.1016/s0024-3205(97)00614-0. PMID 9307051.
  135. ^ Little KY, Ramssen E, Welchko R, Volberg V, Roland CJ, Cassin B (August 2009). "Decreased brain dopamine cell numbers in human cocaine users". Psychiatry Research. 168 (3): 173–80. doi:10.1016/j.psychres.2008.10.034. PMID 19233481. S2CID 27618292.
  136. ^ Sharma HS, Muresanu D, Sharma A, Patnaik R (2009). "Cocaine-induced breakdown of the blood–brain barrier and neurotoxicity". International Review of Neurobiology. 88: 297–334. doi:10.1016/S0074-7742(09)88011-2. ISBN 978-0-12-374504-0. PMID 19897082.
  137. ^ Karch SB (2009). Karch's pathology of drug abuse (4 ed.). Boca Raton: CRC Press. p. 70. ISBN 978-0-8493-7881-2. Archived from the original on 10 September 2017.
  138. ^ Vijayakumar L, Kumar MS, Vijayakumar V (May 2011). "Substance use and suicide". Current Opinion in Psychiatry. 24 (3): 197–202. doi:10.1097/YCO.0b013e3283459242. PMID 21430536. S2CID 206143129.
  139. ^ Moçambique M, Hoffmann A, Roglio V, Kessler F, Dalbosco C, Schuch J, et al. (24 June 2022). "Prevalence of suicide in cocaine users accessing health services: a systematic review and meta-analysis". Revista Brasileira de Psiquiatria. 44 (4). Sao Paulo, Brazil: 441–448. doi:10.47626/1516-4446-2021-2207. PMC 9375660. PMID 35751594.
  140. ^ Ayd FJ (2000). Lexicon of psychiatry, neurology, and the neurosciences (2nd ed.). Philadelphia [u.a.]: Lippincott Williams & Wilkins. p. 256. ISBN 978-0-7817-2468-5.
  141. ^ Shekarchizadeh H, Khami MR, Mohebbi SZ, Ekhtiari H, Virtanen JI (September 2013). "Oral Health of Drug Abusers: A Review of Health Effects and Care". Iranian Journal of Public Health. 42 (9): 929–940. PMC 4453891. PMID 26060654.
  142. ^ Baigent M (2003). "Physical complications of substance abuse: what the psychiatrist needs to know". Curr Opin Psychiatry. 16 (3): 291–296. doi:10.1097/00001504-200305000-00004.
  143. ^ "Cocaine". NIDA.
  144. ^ Paludetto LS, Florence LL, Torales J, Ventriglio A, Castaldelli-Maia JM (29 March 2024). "Mapping the Neural Substrates of Cocaine Craving: A Systematic Review". Brain Sciences. 14 (4): 329. doi:10.3390/brainsci14040329. PMC 11048489. PMID 38671981.
  145. ^ Walsh SL, Stoops WW, Moody DE, Lin SN, Bigelow GE (August 2009). "Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics". Experimental and Clinical Psychopharmacology. 17 (4): 205–216. doi:10.1037/a0016469. PMC 2811070. PMID 19653786.
  146. ^ "Fentanyl-Adulterated Cocaine: Strategies To Address The New Normal". 25 April 2019. Archived from the original on 17 December 2022. Retrieved 17 December 2022.
  147. ^ Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. (GBD 2017 Causes of Death Collaborators) (November 2018). "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017". Lancet. 392 (10159): 1736–1788. doi:10.1016/S0140-6736(18)32203-7. PMC 6227606. PMID 30496103.
  148. ^ Hampton WH, Hanik I, Olson IR (2019). "[Substance Abuse and White Matter: Findings, Limitations, and Future of Diffusion Tensor Imaging Research]". Drug and Alcohol Dependence. 197 (4): 288–298. doi:10.1016/j.drugalcdep.2019.02.005. PMC 6440853. PMID 30875650.
  149. ^ Fernàndez-Castillo N, Cabana-Domínguez J, Corominas R, Cormand B (January 2022). "Molecular genetics of cocaine use disorders in humans". Molecular Psychiatry. 27 (1): 624–639. doi:10.1038/s41380-021-01256-1. PMC 8960411. PMID 34453125.
  150. ^ Hope BT (May 1998). "Cocaine and the AP-1 transcription factor complex". Annals of the New York Academy of Sciences. 844 (1): 1–6. Bibcode:1998NYASA.844....1H. doi:10.1111/j.1749-6632.1998.tb08216.x. PMID 9668659. S2CID 11683570. Archived from the original on 28 July 2020. Retrieved 30 June 2019.
  151. ^ a b Kelz MB, Chen J, Carlezon WA, Whisler K, Gilden L, Beckmann AM, et al. (September 1999). "Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine". Nature. 401 (6750): 272–6. Bibcode:1999Natur.401..272K. doi:10.1038/45790. PMID 10499584. S2CID 4390717.
  152. ^ Colby CR, Whisler K, Steffen C, Nestler EJ, Self DW (March 2003). "Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine". The Journal of Neuroscience. 23 (6): 2488–93. doi:10.1523/JNEUROSCI.23-06-02488.2003. PMC 6742034. PMID 12657709.
  153. ^ a b Nestler EJ, Barrot M, Self DW (September 2001). "DeltaFosB: a sustained molecular switch for addiction". Proceedings of the National Academy of Sciences of the United States of America. 98 (20): 11042–6. Bibcode:2001PNAS...9811042N. doi:10.1073/pnas.191352698. PMC 58680. PMID 11572966.
  154. ^ de Souza MF, Gonçales TA, Steinmetz A, Moura DJ, Saffi J, Gomez R, et al. (April 2014). "Cocaine induces DNA damage in distinct brain areas of female rats under different hormonal conditions". Clinical and Experimental Pharmacology & Physiology. 41 (4): 265–9. doi:10.1111/1440-1681.12218. PMID 24552452. S2CID 20849951.
  155. ^ Alvarenga TA, Andersen ML, Ribeiro DA, Araujo P, Hirotsu C, Costa JL, et al. (January 2010). "Single exposure to cocaine or ecstasy induces DNA damage in brain and other organs of mice". Addiction Biology. 15 (1): 96–9. doi:10.1111/j.1369-1600.2009.00179.x. PMID 19878142. S2CID 21347765.
  156. ^ Dabin J, Fortuny A, Polo SE (June 2016). "Epigenome Maintenance in Response to DNA Damage". Molecular Cell. 62 (5): 712–27. doi:10.1016/j.molcel.2016.04.006. PMC 5476208. PMID 27259203.
  157. ^ a b Kampman KM (October 2019). "The treatment of cocaine use disorder". Science Advances. 5 (10): eaax1532. Bibcode:2019SciA....5.1532K. doi:10.1126/sciadv.aax1532. PMC 6795516. PMID 31663022.
  158. ^ Cocaine Anonymous (13 November 2007). "And All Other Mind-Altering Substances". Archived from the original on 4 March 2009. Retrieved 15 November 2007.
  159. ^ Minozzi S, Cinquini M, Amato L, Davoli M, Farrell MF, Pani PP, et al. (April 2015). Minozzi S (ed.). "Anticonvulsants for cocaine dependence". The Cochrane Database of Systematic Reviews (Systematic Review & Meta-Analysis). 2015 (4): CD006754. doi:10.1002/14651858.CD006754.pub4. PMC 8812341. PMID 25882271.
  160. ^ McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM (2014). "Potential role of N-acetylcysteine in the management of substance use disorders". CNS Drugs. 28 (2): 95–106. doi:10.1007/s40263-014-0142-x. PMC 4009342. PMID 24442756.
  161. ^ Jalali A (October 2023). "Cocaine Nose Correction: A Nonsurgical Approach Using a Novel Hyaluronic Acid Filler". Plastic and Reconstructive Surgery. Global Open. 11 (10): e5329. doi:10.1097/GOX.0000000000005329. PMC 10561808. PMID 37817926.
  162. ^ Taams KO, Taams SJ (January 2022). "The Bilateral Trans Alar Forehead Flap to Reconstruct the Cocaine Nose: A Case Report". Plastic and Reconstructive Surgery. Global Open. 10 (1): e4044. doi:10.1097/GOX.0000000000004044. PMC 8785930. PMID 35083102.
  163. ^ Chatzaraki V, Schweitzer W, Thali MJ, Ampanozi G (September 2019). "Nasal Septum Defects Detected on Postmortem Computed Tomography". The American Journal of Forensic Medicine and Pathology. 40 (3): 279–284. doi:10.1097/PAF.0000000000000482. PMID 30985333.
  164. ^ Schwartz R, Estroff T, Fairbanks D, Hoffmann N (January 1989). "Nasal symptoms associated with cocaine abuse during adolescence". Archives of Otolaryngology--head & Neck Surgery. 115 (1): 63–64. doi:10.1001/archotol.1989.01860250065028. PMID 2909232.
  165. ^ a b "Fraser 'Nose' The Irreparable Damage Cocaine Use Can Do | NHS Lanarkshire". www.nhslanarkshire.scot.nhs.uk.
  166. ^ a b "Patients face losing noses due to cocaine use, medics warn". 9 March 2023.
  167. ^ Schreiber BE, Twigg S, Marais J, Keat AC (April–May 2014). "Saddle-nose deformities in the rheumatology clinic". Ear, Nose, & Throat Journal (Review). 93 (4–5): E45 – E47. PMID 24817241.
  168. ^ a b Pagliaro L, Pagliaro AM (2004). Pagliaros' Comprehensive Guide to Drugs and Substances of Abuse. Washington, D.C.: American Pharmacists Association. ISBN 978-1-58212-066-9.
  169. ^ Hansen FV, Kiehn OT, Lomholt AF, Ringdom H, Aanæs K (October 2023). "[Not Available]". Ugeskrift for Laeger. 185 (40). PMID 37874002.
  170. ^ Millard DR, Mejia FA (February 2001). "Reconstruction of the nose damaged by cocaine". Plastic and Reconstructive Surgery. 107 (2): 419–424. doi:10.1097/00006534-200102000-00018. PMID 11214057.
  171. ^ "Doctors in Belgium see serious nose lesions amid rising cocaine use". euronews. 28 March 2024.
  172. ^ Overdose Death Rates. By National Institute on Drug Abuse (NIDA).
  173. ^ O'Leary ME, Hancox JC (May 2010). "Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias". British Journal of Clinical Pharmacology. 69 (5): 427–442. doi:10.1111/j.1365-2125.2010.03629.x. PMC 2856043. PMID 20573078.
  174. ^ "Cocaine". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. 2017. PMID 31643773.
  175. ^ "Cocaine use fuels record high in drug deaths". www.bbc.com. 23 October 2024.
  176. ^ Laizure SC, Mandrell T, Gades NM, Parker RB (January 2003). "Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases". Drug Metabolism and Disposition. 31 (1): 16–20. doi:10.1124/dmd.31.1.16. PMID 12485948.
  177. ^ Pergolizzi J, Breve F, Magnusson P, LeQuang JA, Varrassi G (February 2022). "Cocaethylene: When Cocaine and Alcohol Are Taken Together". Cureus. 14 (2): e22498. doi:10.7759/cureus.22498. PMC 8956485. PMID 35345678.
  178. ^ Liu X, Singer ME (June 2023). "Intentional use of both opioids and cocaine in the United States". Preventive Medicine Reports. 33: 102227. doi:10.1016/j.pmedr.2023.102227. PMC 10201855. PMID 37223567.
  179. ^ Barnett G, Hawks R, Resnick R (1981). "Cocaine pharmacokinetics in humans". Journal of Ethnopharmacology. 3 (2–3): 353–66. doi:10.1016/0378-8741(81)90063-5. PMID 7242115.; Jones, supra note 19; Wilkinson et al., Van Dyke et al.
  180. ^ Sachkova A, Doetsch DA, Jensen O, Brockmöller J, Ansari S (October 2021). "How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter". Biochemical Pharmacology. 192: 114751. doi:10.1016/j.bcp.2021.114751. PMID 34464621.
  181. ^ Tega Y, Tabata H, Kurosawa T, Kitamura A, Itagaki F, Oshitari T, et al. (January 2021). "Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter". Journal of Pharmaceutical Sciences. 110 (1): 397–403. doi:10.1016/j.xphs.2020.09.001. PMID 32898521.
  182. ^ Chapy H, Smirnova M, André P, Schlatter J, Chiadmi F, Couraud PO, et al. (October 2014). "Carrier-mediated cocaine transport at the blood–brain barrier as a putative mechanism in addiction liability". The International Journal of Neuropsychopharmacology. 18 (1): pyu001. doi:10.1093/ijnp/pyu001. PMC 4368859. PMID 25539501.
  183. ^ Sachkova A, Jensen O, Dücker C, Ansari S, Brockmöller J (September 2022). "The mystery of the human proton-organic cation antiporter: One transport protein or many?". Pharmacology & Therapeutics. 239: 108283. doi:10.1016/j.pharmthera.2022.108283. PMID 36162727. S2CID 252527522.
  184. ^ Ambre J, Ruo TI, Nelson J, Belknap S (November 1988). "Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans". Journal of Analytical Toxicology. 12 (6): 301–6. doi:10.1093/jat/12.6.301. PMID 3244269.
  185. ^ Kolbrich EA, Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA (October 2006). "Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration". Journal of Analytical Toxicology. 30 (8): 501–10. doi:10.1093/jat/30.8.501. PMID 17132243. Archived from the original on 18 July 2012.
  186. ^ "Schaffer Library of Drug Policy: Urine Testing for Cocaine". Retrieved 3 April 2025.
  187. ^ R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 9th edition, Biomedical Publications, Seal Beach, California, 2011, pp. 390–394.
  188. ^ Czykanski M (30 December 2015). "Cocaine Metabolites in Hair". Chemistry Views. Archived from the original on 22 July 2019. Retrieved 22 July 2019.
  189. ^ Proebstl L, Kamp F, Manz K, Krause D, Adorjan K, Pogarell O, et al. (June 2019). "Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies". European Psychiatry. 59: 15–24. doi:10.1016/j.eurpsy.2019.03.003. PMID 30981746.
  190. ^ "How does cocaine produce its effects?". Archived from the original on 18 January 2022. Retrieved 12 May 2021.
  191. ^ Wise RA, Robble MA (January 2020). "Dopamine and Addiction". Annual Review of Psychology. 71 (1): 79–106. doi:10.1146/annurev-psych-010418-103337. PMID 31905114.
  192. ^ Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, et al. (January 2001). "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin". Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707. S2CID 15573624. (Table V. on page 37)
  193. ^ Hummel M, Unterwald EM (April 2002). "D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action". Journal of Cellular Physiology. 191 (1): 17–27. doi:10.1002/jcp.10078. PMID 11920678. S2CID 40444893.
  194. ^ Carta M, Allan AM, Partridge LD, Valenzuela CF (January 2003). "Cocaine inhibits 5-HT3 receptor function in neurons from transgenic mice overexpressing the receptor". European Journal of Pharmacology. 459 (2–3): 167–9. doi:10.1016/S0014-2999(02)02867-4. PMID 12524142.
  195. ^ Filip M, Bubar MJ, Cunningham KA (September 2004). "Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses". The Journal of Pharmacology and Experimental Therapeutics. 310 (3): 1246–54. doi:10.1124/jpet.104.068841. PMID 15131246. S2CID 25809734.
  196. ^ Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, et al. (July 2008). "The binding sites for cocaine and dopamine in the dopamine transporter overlap". Nature Neuroscience. 11 (7): 780–9. doi:10.1038/nn.2146. PMC 2692229. PMID 18568020.
  197. ^ Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, et al. (April 1997). "Relationship between subjective effects of cocaine and dopamine transporter occupancy". Nature. 386 (6627): 827–830. Bibcode:1997Natur.386..827V. doi:10.1038/386827a0. PMID 9126740.
  198. ^ a b Heal DJ, Gosden J, Smith SL (December 2014). "Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine". Neuropharmacology. CNS Stimulants. 87: 19–40. doi:10.1016/j.neuropharm.2014.06.012. PMID 24953830.
  199. ^ Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, et al. (September 1996). "Relationship between psychostimulant-induced "high" and dopamine transporter occupancy". Proceedings of the National Academy of Sciences of the United States of America. 93 (19): 10388–10392. doi:10.1073/pnas.93.19.10388. PMC 38394. PMID 8816810.
  200. ^ Schmitt KC, Reith ME (2011). "The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors". PLOS ONE. 6 (10): e25790. Bibcode:2011PLoSO...625790S. doi:10.1371/journal.pone.0025790. PMC 3197159. PMID 22043293.
  201. ^ "Sigma Receptors Play Role in Cocaine-induced Suppression of Immune System". Sciencedaily.com. 6 May 2003. Archived from the original on 12 January 2011. Retrieved 9 March 2010.
  202. ^ Lluch J, Rodríguez-Arias M, Aguilar MA, Miñarro J (November 2005). "Role of dopamine and glutamate receptors in cocaine-induced social effects in isolated and grouped male OF1 mice". Pharmacology Biochemistry and Behavior. 82 (3): 478–87. doi:10.1016/j.pbb.2005.10.003. PMID 16313950. S2CID 13307446.
  203. ^ Knuepfer MM (March 2003). "Cardiovascular disorders associated with cocaine use: myths and truths". Pharmacology & Therapeutics. 97 (3): 181–222. doi:10.1016/S0163-7258(02)00329-7. PMID 12576134.
  204. ^ "Drugbank website "drug card", "(DB00907)" for Cocaine: Giving ten targets of the molecule in vivo, including dopamine/serotonin sodium channel affinity & K-opioid affinity". Drugbank.ca. Archived from the original on 20 February 2010. Retrieved 9 March 2010.
  205. ^ Uz T, Akhisaroglu M, Ahmed R, Manev H (December 2003). "The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice". Neuropsychopharmacology. 28 (12): 2117–23. doi:10.1038/sj.npp.1300254. PMID 12865893.
  206. ^ McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, et al. (June 2005). "Regulation of dopaminergic transmission and cocaine reward by the Clock gene". Proceedings of the National Academy of Sciences of the United States of America. 102 (26): 9377–81. Bibcode:2005PNAS..102.9377M. doi:10.1073/pnas.0503584102. PMC 1166621. PMID 15967985.
  207. ^ Aguinaga D, Medrano M, Cordomí A, Jiménez-Rosés M, Angelats E, Casanovas M, et al. (February 2019). "Cocaine Blocks Effects of Hunger Hormone, Ghrelin, Via Interaction with Neuronal Sigma-1 Receptors". Molecular Neurobiology. 56 (2): 1196–1210. doi:10.1007/s12035-018-1140-7. hdl:2445/127306. PMID 29876881. S2CID 46964405.
  208. ^ Bouhlal S, Ellefsen KN, Sheskier MB, Singley E, Pirard S, Gorelick DA, et al. (November 2017). "Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses". Drug and Alcohol Dependence. 180: 68–75. doi:10.1016/j.drugalcdep.2017.07.033. PMC 5654385. PMID 28881319.
  209. ^ Carey RJ, Damianopoulos EN, Shanahan AB (January 2008). "Cocaine effects on behavioral responding to a novel object placed in a familiar environment". Pharmacology Biochemistry and Behavior. 88 (3): 265–71. doi:10.1016/j.pbb.2007.08.010. PMID 17897705. S2CID 22711773.
  210. ^ "Content Background: Chemical Characteristics of Cocaine". duke.edu. Archived from the original on 8 July 2024. Retrieved 4 May 2020.
  211. ^ Humphrey AJ, O'Hagan D (October 2001). "Tropane alkaloid biosynthesis. A century-old problem unresolved". Natural Product Reports. 18 (5): 494–502. doi:10.1039/b001713m. PMID 11699882.
  212. ^ Amara SB, Koslowski T, Zaidi A (2021). "Quantum Chemistry of Cocaine and its Isomers I: Energetics, Reactivity and Solvation". South African Journal of Chemistry. 75. doi:10.17159/0379-4350/2021/v75a3.
  213. ^ Drake LR, Scott PJ (October 2018). "DARK Classics in Chemical Neuroscience: Cocaine". ACS Chemical Neuroscience. 9 (10): 2358–2372. doi:10.1021/acschemneuro.8b00117. PMC 6197930. PMID 29630337.
  214. ^ Leete E (August 1990). "Recent Developments in the Biosynthesis of the Tropane Alkaloids1". Planta Medica. 56 (4): 339–352. Bibcode:1990PlMed..56..339L. doi:10.1055/s-2006-960979. PMID 2236285.
  215. ^ "Genetically modified tobacco plant produces cocaine in its leaves". New Scientist. Archived from the original on 27 November 2022. Retrieved 27 November 2022.
  216. ^ "Drug torches 'don't always work'". BBC News. 22 July 2009.
  217. ^ "Drug torches for bouncers 'don't always spot cocaine'". BBC News. 14 June 2013.
  218. ^ "Meet the Chemist Behind Many Popular—and Faulty—Police Drug Kits". Pacific Standard. 22 June 2016. Archived from the original on 8 August 2020. Retrieved 21 April 2020.
  219. ^ Gabrielson R, Sanders T (7 July 2016). "How a $2 Roadside Drug Test Sends Innocent People to Jail". The New York Times. Archived from the original on 1 January 2022. Retrieved 21 April 2020.
  220. ^ Travnikoff B (1 April 1983). "Semiquantitative screening test for cocaine". Analytical Chemistry. 55 (4): 795–796. doi:10.1021/ac00255a048. ISSN 0003-2700.
  221. ^ Busnel R, Manrique López H (July 2023). "The political economy of a failed drug reform: Insights from Peru's main legal coca valley". The International Journal on Drug Policy. 117: 104050. doi:10.1016/j.drugpo.2023.104050. PMID 37267739.
  222. ^ Grisaffi T, Ledebur K (31 March 2016). "Citizenship or Repression? Coca, Eradication and Development in the Andes". Stability: International Journal of Security and Development. 5 (1). doi:10.5334/sta.440. ISSN 2165-2627.
  223. ^ "Cocaine". DEA.
  224. ^ Franklin J (18 August 2009). "The world's first cocaine bar". The Guardian. ISSN 0261-3077. Archived from the original on 12 January 2017. Retrieved 23 December 2016.
  225. ^ Grisaffi T. "The Cato Accord: Bolivia's Humane and Effective Approach to Controlling Coca Cultivation" (PDF). ain-bolivia.org. Archived (PDF) from the original on 3 May 2016. Retrieved 12 January 2017.
  226. ^ "Therapeutic Goods (Poisons Standard—October 2023) Instrument 2023". Federal Register of Legislation. Australian Government. 26 September 2023. Retrieved 22 January 2024.
  227. ^ "Illicit drug use". Australian Institute of Health and Welfare. 13 December 2023. Archived from the original on 20 January 2024. Retrieved 22 January 2024.
  228. ^ "Misuse of Drugs Act 1981" (PDF). Western Australian Legislation. Government of Western Australia Department of Justice Parliamentary Counsel's Office. Archived (PDF) from the original on 17 February 2024. Retrieved 22 January 2024.
  229. ^ a b c d Gootenberg P, ed. (1999). Cocaine: Global Histories. London: Routledge. ISBN 978-0-203-02646-5.
  230. ^ Madge T (2001). White Mischief: A Cultural History of Cocaine. Edinburgh: Mainstream Publishing Company. p. 106. ISBN 978-1-84018-405-1.
  231. ^ "Narcotic drug addiction". American Medicine. American-Medicine Publishing Company: 799. November 1915. Archived from the original on 9 May 2018. Retrieved 29 April 2018.
  232. ^ Brown E, Barganier G (2018). Race and Crime: Geographies of Injustice. Oakland, California: University of California Press. pp. 207–209. ISBN 978-0-520-29418-9. Archived from the original on 12 April 2023. Retrieved 21 November 2021.
  233. ^ Moore NM (2015). The Political Roots of Racial Tracking in American Criminal Justice. New York, NY: Cambridge University Press. p. 270. ISBN 978-1-107-02297-3. Archived from the original on 6 April 2023. Retrieved 21 November 2021.
  234. ^ Glaser J (2015). Suspect Race: Causes and Consequences of Racial Profiling. New York, NY: Oxford University Press. p. 7. ISBN 978-0-19-537040-9. Archived from the original on 12 April 2023. Retrieved 21 November 2021.
  235. ^ https://www.unodc.org/documents/data-and-analysis/WDR_2025/Press_release_WDR_2025_English.pdf. {{cite web}}: Missing or empty |title= (help)
  236. ^ https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_Special_points_of_interest.pdf. {{cite web}}: Missing or empty |title= (help)
  237. ^ "Field Listing – Illicit drugs (by country)". Cia.gov. Archived from the original on 29 December 2010. Retrieved 15 January 2011.
  238. ^ "How the drug wars impact Latin America and the Caribbean development? | Feature from King's College London". www.kcl.ac.uk.
  239. ^ Janda KD, Treweek JB (December 2011). "Vaccines targeting drugs of abuse: is the glass half-empty or half-full?". Nature Reviews. Immunology. 12 (1): 67–72. doi:10.1038/nri3130. PMID 22173478.
  240. ^ Anthenelli RM, Somoza E (September 2010). "Vaccine for cocaine addiction: A promising new immunotherapy" (PDF). Current Psychiatry. 9 (9): 16–20.
  241. ^ Bremer PT, Schlosburg JE, Banks ML, Steele FF, Zhou B, Poklis JL, et al. (June 2017). "Development of a Clinically Viable Heroin Vaccine". Journal of the American Chemical Society. 139 (25): 8601–8611. Bibcode:2017JAChS.139.8601B. doi:10.1021/jacs.7b03334. PMC 5612493. PMID 28574716.
  242. ^ Teobaldo L (1994). "The Standard Low Dose of Oral Cocaine: Used for Treatment of Cocaine Dependence" (PDF). Substance Abuse. 15 (4): 215–220. Archived (PDF) from the original on 2 June 2014.
  243. ^ Mariani JJ, Khantzian EJ, Levin FR (March 2014). "The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update". The American Journal on Addictions. 23 (2): 189–193. doi:10.1111/j.1521-0391.2013.12086.x. PMC 4227391. PMID 25187055.
  244. ^ Kandel ER, Kandel DB (September 2014). "Shattuck Lecture. A molecular basis for nicotine as a gateway drug". The New England Journal of Medicine. 371 (10): 932–943. doi:10.1056/NEJMsa1405092. PMC 4353486. PMID 25184865.
  245. ^ Keyes KM, Hamilton A, Kandel DB (June 2016). "Birth Cohorts Analysis of Adolescent Cigarette Smoking and Subsequent Marijuana and Cocaine Use". American Journal of Public Health. 106 (6): 1143–1149. doi:10.2105/AJPH.2016.303128. PMC 4880234. PMID 27077359.
  246. ^ Ren M, Lotfipour S (August 2019). "Nicotine Gateway Effects on Adolescent Substance Use". The Western Journal of Emergency Medicine. 20 (5): 696–709. doi:10.5811/westjem.2019.7.41661. PMC 6754186. PMID 31539325.
  247. ^ Griffin EA, Melas PA, Zhou R, Li Y, Mercado P, Kempadoo KA, et al. (November 2017). "Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5". Science Advances. 3 (11): e1701682. Bibcode:2017SciA....3E1682G. doi:10.1126/sciadv.1701682. PMC 5665598. PMID 29109977.
  248. ^ Anderson EM, Penrod RD, Barry SM, Hughes BW, Taniguchi M, Cowan CW (August 2019). "It is a complex issue: emerging connections between epigenetic regulators in drug addiction". The European Journal of Neuroscience. 50 (3): 2477–2491. doi:10.1111/ejn.14170. PMID 30251397. S2CID 52816486.
  249. ^ Lopez-Quintero C, Pérez de los Cobos J, Hasin DS, Okuda M, Wang S, Grant BF, et al. (May 2011). "Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)". Drug and Alcohol Dependence. 115 (1–2): 120–130. doi:10.1016/j.drugalcdep.2010.11.004. PMC 3069146. PMID 21145178.
  250. ^ Bickel WK, Snider SE, Quisenberry AJ, Stein JS, Hanlon CA (2016). "Competing neurobehavioral decision systems theory of cocaine addiction". Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities. Progress in Brain Research. Vol. 223. pp. 269–293. doi:10.1016/bs.pbr.2015.07.009. ISBN 978-0-444-63545-7. PMC 5495192. PMID 26806781.
  251. ^ Dimitrijevic N, Dzitoyeva S, Manev H (August 2004). "An automated assay of the behavioral effects of cocaine injections in adult Drosophila". Journal of Neuroscience Methods. 137 (2): 181–184. doi:10.1016/j.jneumeth.2004.02.023. PMID 15262059. S2CID 19882594.
  252. ^ Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR (July 2005). "Vaccine pharmacotherapy for the treatment of cocaine dependence". Biol. Psychiatry. 58 (2): 158–64. doi:10.1016/j.biopsych.2005.04.032. PMID 16038686. S2CID 22415520.
  253. ^ Hesse M (2002). Alkaloids: Nature's Curse or Blessing?. Weinheim: Wiley-VCH. p. 304. ISBN 978-3-906390-24-6.
  254. ^ "Drug that spans the ages: The history of cocaine". London: The Independent (UK). 2006. Archived from the original on 28 February 2010. Retrieved 30 April 2010.
  255. ^ Luch A (3 April 2009). Molecular, Clinical and Environmental Toxicology. Basel Boston: Springer Science & Business Media. p. 20. ISBN 978-3-7643-8336-7.
  256. ^ Niemann A (1860). "Ueber eine neue organische Base in den Cocablättern". Archiv der Pharmazie. 153 (2 and 3): 129–155, 291–308. doi:10.1002/ardp.18601530202. S2CID 98195820. Archived from the original on 28 July 2020. Retrieved 30 June 2019.
  257. ^ Harper D. "Cocaine". Online Etymology Dictionary.
  258. ^ Halsted W (1885). "Practical comments on the use and abuse of cocaine". New York Medical Journal. 42: 294–295.
  259. ^ Corning JL (1885). "An experimental study". New York Medical Journal. 42: 483.
  260. ^ "Cocaine". American Heritage Dictionary. Archived from the original on 3 January 2023. Retrieved 3 January 2023.

Further reading

[edit]
[edit]